Native American Research Centers for Health (NARCH) Grants, 4235-4248 [08-243]
Download as PDF
Federal Register / Vol. 73, No. 16 / Thursday, January 24, 2008 / Notices
Dated: January 9, 2008.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E8–1200 Filed 1–23–08; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Indian Health Service
Native American Research Centers for
Health (NARCH) Grants
Announcement Type: New and
Competing Continuations.
Funding Announcement Number:
HHS–2009–IHS–NARCHV–0001.
Catalog of Federal Domestic
Assistance Number(s): 93.933.
Key Dates: Letter of Intent Deadline:
March 15, 2008.
Application Deadline Date: May 16,
2008.
Review Date: October, 2008.
Earliest Anticipated Start Date: June
1, 2009.
jlentini on PROD1PC65 with NOTICES
I. Funding Opportunity Description
The Indian Health Service (IHS), in
conjunction with the National Institute
of General Medical Sciences (NIGMS)
and other institutes of the National
Institutes of Health (NIH) announces
competitive grant applications for
Native American Research Centers for
Health (NARCH), an initiative to
support new and/or continuing centers
or projects funded under the NARCH
grant program. This funding mechanism
will develop further opportunities for
conducting research and research
training to meet the needs of American
Indian/Alaska Native (AI/AN)
communities. This program is
authorized under the Snyder Act, 25
U.S.C. 13, the Public Health Service Act,
42 U.S.C. 241 as amended, and the
Indian Health Care Improvement Act, 25
U.S.C. 1602(a)(b)(16). This program is
described at 93.933 in the Catalog of
Federal Domestic Assistance.
Background Information: TheAI/AN
Tribal nations and communities have
long experienced health status worse
than that of other Americans. Although
major gains in reducing health
disparities were made during the last
half of the twentieth century, most gains
stopped by the mid-1980s (Trends in
Indian Health 1998–99) and a few
diseases, e.g., diabetes, worsened. ‘‘All
Indian’’ rates contain marked variation
among the IHS Areas or regions
(Regional Differences in Indian Health
1998–99); and variation by Tribe exists
within Areas as well. The Trends and
Regional Differences reference can be
VerDate Aug<31>2005
20:35 Jan 23, 2008
Jkt 214001
found at the IHS Web site at: https://
www.ihs.gov/NonMedicalPrograms/
IHS_Stats. Although the AI/AN
mortality rates for all cancers are about
20 percent lower than the U.S. rates for
all races, there is variation among IHS
Areas for specific cancers. Moreover, the
favorable AI/AN mortality rates for
some cancers may be due to markedly
lower incidence rates partly offset by
higher case-fatality rates. Unfamiliarity
with modern health care may adversely
influence health status among the
elderly, the low-income elderly, and
Tribes, and also may reduce the
acceptability of health research among
them. The daunting tasks confronting
Tribes, researchers, and health care and
public health programs in the beginning
of the twenty-first century are to resume
the reduction of health disparities that
had occurred through the 1980s, to
reverse the worsening in a few diseases,
to maintain and strengthen the favorable
status, and to reduce the disparities
among and within Areas and Tribes.
Factors known to contribute to health
status and disparities are complex, and
include underlying biology, physiology,
and genetics, as well as ethnicity,
culture, socioeconomic status, gender/
sex, age, geographical access to care,
and levels of insurance. Additional
factors known to contribute to health
status and dispariteis include:
1. Family, home, and work
environments;
2. General or culturally specific health
practices;
3. Social support systems;
4. Lack of access to culturallyappropriate health care; and
5. Attitudes toward health.
Yet none of these along or in
combination accounts for all
documented differences. Health
disparities of AI/ANs may also reflect a
lack of in-depth research relevant to
improving their health status. Many AI/
ANs distrust research for historical
reasons. One approach that combats this
distrust is to ensure that Tribes are the
managing partners in training and
research that involves them, as for
example, in community-based
participatory research (CBPR) (i.e., a
collaborative research process between
researchers and community
representatives). This approach is
especially helpful to design both
training relevant to researchers from
Tribal communities, and research
relevant to the health needs of the
communities.
Research Objectives: The NARCH
initiative will support partnerships
between Federally Recognized AI/AN
Tribes Organizations (including national
and area Indian Health Boards, and
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
4235
Tribal colleges meeting the definition of
a Tribal organization as defined by 25
U.S.C. 1603(e)) and institutions that
conduct intensive academic-level
biomedical, behavioral and health
services research. These partnerships
are called Native American Research
Centers for Health (NARCH). Due to the
complexity of factors contributing to the
health and disease of AI/ANs, and to
their health disparities compared with
other Americans, the collaborative
efforts of the agencies of the Department
of Health and Human Services (HHS)
and the collaboration of researchers and
AI/AN communities are needed to
achieve significant improvements in the
health status of AI/AN people. To
accomplish this goal, in addition to
objectives set by the Tribe, Tribal
Organization or Indian Health Boards,
the IHS NARCH program will pursue
the following program objectives:
• To develop a cadre of AI/AN
scientists and Health Professionals—
Opportunities are needed to develop
more AI/AN scientists and health
professionals engaged in research, and
to conduct biomedical, clinical,
behavioral and health services research
that is responsive to the needs of the AI/
AN community and the goals of this
initiative. Faculty/researchers and
students at each proposed NARCH will
develop investigator-initiated,
scientifically meritorious research
projects, including pilot research
projects, and will be supported through
science education projects designed to
increase the numbers of, and to improve
the research skills of, AI/AN
investigators and investigators involved
with AI/ANs.
• To enhance Partnerships and
reduce distrust of research by AI/AN
communities—Recent community-based
participatory research suggests that AI/
AN communities can work
collaboratively in partnership with
health researchers to further the
research needs of AI/ANs. Fully
utilizing all cultural and scientific
knowledge, strengths, and
competencies, such partnerships can
lead to better understanding of the
biological, genetic, behavioral,
psychological, cultural, social, and
economic factors either promoting or
hindering improved health status of AI/
ANs, and generate the development and
evaluation of interventions to improve
their health status. Community distrust
of research and researchers will be
reduced by offering the Tribe greater
control over the research process.
• To Reduce Health Disparities—In
the Indian Health Care Improvement
Act, Pub. L. 94–437 (as amended), IHS
was legislatively mandated to improve
E:\FR\FM\24JAN1.SGM
24JAN1
4236
Federal Register / Vol. 73, No. 16 / Thursday, January 24, 2008 / Notices
jlentini on PROD1PC65 with NOTICES
the delivery of effective health care to
AI/ANs. In the NIH Revitalization Act of
1993, NIH was encouraged to increase
the number of under-represented
minorities participating in biomedical,
clinical, and behavioral research,
including studies on drug abuse and
alcoholism, and the examination of the
role of resiliency in the prevention and
treatment of those conditions. Also, the
‘‘Initiative to Eliminate Racial and
Ethnic Disparities in Health’’ by HHS
(https://www.omhrc.gov/rah) encouraged
NIH to help reduce health disparities. In
response to these priorities, the IHS and
NIH have established a collaboration to
support the NARCH.
Reducing health disparities among
AI/AN communities and individuals
may be fostered by greater
understanding of how to enhance their
strengths and resilience. While AI/AN
communities have relied on health
research and medical science to reduce
health disparities, they have also relied
on their own psychological,
organizational, and cultural assets and
strengths to survive major harms and
disruptions over the centuries, and to
rebound from insults to health.
The mission of NIH is to acquire new
knowledge that will lead to better health
by understanding the processes
underlying health and disease that in
turn will help prevent, detect, diagnose,
and treat disease and disability. The
NARCH initiative works toward the NIH
mission by supporting research that
discovers the interrelationships among
the many factors that contribute to
health and disease, and by helping to
train and promote AI/AN researchers
and researchers concerned with AI/AN
health.
II. Award Information
Type of Awards: Grant.
Estimated Funds Available: The
estimated funds (total costs) available
for the first year of support for the entire
initiative is expected to be at least $3.0
million in Fiscal Year 2009. The actual
amount may vary, depending on the
response to the request for applications
(RFA) and availability of funds. An
applicant may request a project period
not to exceed four years of support, and
direct costs not to exceed $1,000,000 per
center or $500,000 per project (research
or training) in the first year of each
award. Direct costs to the applicant
include the total cost of each
subcontract (subcontractor direct plus
subcontractor indirect costs).
Anticipated Number of Awards: An
estimated five to fifteen awards will be
made under the program.
Award Amount: $100,000–$1,000,000
per year.
VerDate Aug<31>2005
20:35 Jan 23, 2008
Jkt 214001
III. Eligibility Information
The new or existing NARCH must be
a working partnership of the eligible AI/
AN organization and of the researchintensive institution. Applicants eligible
to receive the NARCH award are
Federally recognized Tribes and Tribal
organizations as defined under the
Indian Health Care Improvement Act, 25
U.S.C. 1603(d) and (3), including
eligible Indian Health Boards or Tribal
Colleges applying on behalf of eligible
Federally recognized Tribes or Tribal
organizations. As the grantee, the
eligible AI/AN organization will define
criteria and eligibility for participation
in all aspects of the partnership,
consistent with this announcement. A
minimum of 30 percent of the grant
funds must be budgeted in the
application to remain with the eligible
AI/AN organization(s); that is, no more
than 70 percent of the application’s total
budget may be contained in subcontract
budgets of the non-eligible
subcontracting partner institutions or
organization.
1. Eligible Applicants—The AI/AN
applicant must be one of the following:
• A federally-recognized AI/AN
Tribe, as defined under 25 U.S.C.
1603(d); or
• A Tribal organization, as defined
under 25 USC 1603(e), including Tribal
Colleges or health boards meeting this
definition; or
• A consortium of two or more of
those Tribes or Tribal organizations.
Applicants other than Tribes must
provide proof of non-profit status.
2. Cost Sharing or Matching—The
NARCH program does not require
matching funds or cost sharing.
3. The Research-Intensive Partner:
The Research-Intensive Partner must be
an accredited public or private
nonprofit university or other institution
that has an established record of
conducting research into the health
problems of AI/AN; has demonstrated a
commitment to enhancing the capability
of AI/AN faculty/researchers, students,
investigators, and communities to
engage in biomedical, behavioral,
clinical and health services research;
and has demonstrated a commitment to
mentoring AI/AN faculty/researchers,
students, and investigators.
4. Principal Investigator: The
Principal Investigator, the individual
responsible for the administration
(including fiscal management) of the
overall project, must have his/her
primary appointment with the AI/AN
applicant organization. Special
arrangements of employment, such as
inter-organizational personnel
agreements, are permissible. The
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
Principal Investigator may be, but is not
required to be, the NARCH Program
Director or a Research Project
Investigator. The NARCH Principal
Investigator may or may not have formal
academic/research credentials, but if
not, then the NARCH Program Director
must be so qualified.
The traditional NIH research project
grant consists of a single Principal
Investigator (PI) working with a small
group of subordinates on an
independent research project. Although
this model clearly continues to work
well and encourages creativity and
productivity, it does not always work
well for multidisciplinary efforts and
collaboration. Increasingly, healthrelated research involves teams that
vary in terms of size, hierarchy, location
of participants, goals, disciplines, and
structure. There is growing consensus
that team science would be encouraged
if more than one PI could be recognized
on individual awards. The NIH has
adopted a multiple-PI model, as recently
directed by the Office of Science and
Technology Policy. All agencies that
have research and research-related
programs must offer the multiple-PI
model as an option. Note, it is only an
option, not a requirement. The
traditional NARCH division of roles
between Principal Investigator and
Project Director will usually address
these issues to a satisfactory degree. For
additional information regarding the
new multiple-PI model, please click on
the following Web site: https://
grants.nih.gov/grants/multi_pi/
index.htm.
5. NARCH Program Director: The
NARCH Program Director is the
individual responsible for the day-today leadersip and management of the
research and training programs within
the proposed NARCH. The Program
Director may be, but is not required to
be, the Student and Faculty/Researcher
Development Director or a Research
Project Investigator. The NARCH
Program Director may or may not have
formal academic/research credentials,
but if not, then the Principal
Investigator must be so qualified.
6. Student and Faculty/Researcher
Development Director and Participants:
The NARCH initiative is an institutional
developmental grant mechanism that
places an emphasis on the continual
development of students and faculty/
researchers. If a new Student and/or
Faculty/Researcher Development
Program is proposed in the current
application, then the Principal
Investigator of that project is expected to
be the NARCH Student and Faculty
Development Director. In order to be
included as the Student and Faculty
E:\FR\FM\24JAN1.SGM
24JAN1
jlentini on PROD1PC65 with NOTICES
Federal Register / Vol. 73, No. 16 / Thursday, January 24, 2008 / Notices
Development Director, the prospective
director must have a faculty/researcher
appointment at the research-intensive
institution (or equivalent appointment
at the AI/AN organization or other
consortium partner) and must
demonstrate that he/she has the
knowledge, skills, and capabilities to
mentor students and faculty/researchers
and to generate and direct development
and mentoring programs.
The Student and Faculty
Development Director may be the
NARCH Program Director. Faculty/
researchers and students should be
supported in research education
activities that improve their skills and
abilities to be successful at the next
stage of their professional development.
To be included as a participant for
faculty/researcher development in the
proposed NARCH, the individual must
have a faculty/researcher appointment
at the research-intensive institution or
equivalent appointment at the AI/AN
organization or consortium partner.
7. Research Project Investigators: The
NARCH initiative is an institutional
developmental grant mechanism that
places an emphasis on continual
improvement of the research
competitiveness of the research
investigators. In order to be included as
a research project investigator in the
NARCH, a prospective investigator must
have a faculty appointment at the
research-intensive institution or
equivalent appointment at the AI/AN
organization or other consortium
partner, and must show that he/she has
the need, based on institutional,
departmental, and professional
development plans, to enhance his/her
research knowledge, skills, and
capabilities by engaging in the proposed
research program and associated
activities.
8. Tribal Approval of the Application:
It is the policy of the IHS that all
research involving AI/AN Tribes be
approved by the Tribal governments
with jurisdiction. Therefore, the
following documentation is required as
part of the application for new or
continuing centers or additional
NARCH projects:
• Tribal Resolution: If the applicant is
an Indian Tribe or Tribal organization,
a resolution from the Tribal government
of all Tribes to be served supporting the
project must accompany the application
submission. Applications by Tribal
organizations will not require
resolutions if the current Tribal
resolutions under which they operate
would encompass the proposed
activities. In this instance a copy of the
current resolution must accompany the
application. The listed Tribes to be
VerDate Aug<31>2005
20:35 Jan 23, 2008
Jkt 214001
served by the project in the proposal
must match the set of appended
resolutions. If a resolution from an
appropriate representative of each Tribe
to be served is not submitted prior to
November 1, 2008, the application will
be considered incomplete and will not
be considered for funding.
An official signed resolution must be
received by November 1, 2008 to the
Division of Grants Operation by (DGO),
IHS, at the Reyes Building, 801
Thompson Avenue, TMP 360, Rockville,
MD 20852. A grant will not be awarded
unless the signed resolution is received.
Please include the funding opportunity
number, as a reference to this
announcement, if the resolutions are
submitted as a separate mailing.
9. Mechanism of Support: Awards
under this initiative will be
administered using the competing
institutional grant mechanism of the
IHS, and will be reviewed using the NIH
S06 mechanism.
IV. Application and Submission
Information
1. Address To Request Application
Package: NARCH Program Official,
Reyes Building, 801 Thompson Avenue,
Rockville, MD 20852 or by e-mail to
narch@ihs.gov. Applicants are strongly
encouraged to establish eligibility of
their proposed applications prior to
submission. Inquiries about eligibility
should be addressed to Alan
Trachtenberg, MD, MPH, at (301) 443–
0578 or by E-mail to narch@ihs.gov. The
application package, including
supplemental instructions will be
posted on the IHS Research Program
Web site, at: https://www.ihs.gov/
MedicalPrograms/Research/narch.cfm.
The NIH PHS 398 application
instructions are available in an
interactive format at: https://
grants.nih.gov/grants/funding/phs398/
phs398.html. Applicants must use the
currently approved version of the PHS
398. For further assistance contact
GrantsInfo, Telephone (301) 435–0714,
E-mail: GrantsInfo@nih.gov,
Telecommunications for the hearing
impaired: TTY 301–451–0088.
Submit a typed and signed original
application, including the Checklist,
and one (1) single-sided photocopy of
the entire application (including
Appendices and supporting documents)
in one package to: Division of Grants
Operations, Indian Health Service,
Reyes Building, 801 Thompson Avenue,
TMP 360, Rockville, MD 20852–1627
(zip code is unchanged for express/
courier services), Telephone: (301) 443–
5204.
At the time of submission, applicants
must also send four (4) additional
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
4237
single-sided photocopied and signed
applications, including the Checklist,
Appendices, and supporting
documentation to: Center for Scientific
Review (CSR), National Institutes of
Health, 6701 Rockledge Drive, Room
6160—MSC 7892, Bethesda, MD 20892–
7720, Bethesda, MD 20817 (for express
or courier service). Telephone: (301)
435–0715. The CSR no longer accepts
hand delivered applications.
The RFA label available at https://
grants1.nih.gov/grants/funding/phs398/
label-bk.pdf in the PDF format, must be
affixed to the bottom-face page of the
application. Type this RFA number:
‘‘NOT GM–08–115’’ on the label. Failure
to use this label could delay processing
the application and it may not reach the
review committee in time for review. In
addition, the ‘‘Native American
Research Centers for Health’’ and the
RFA number must be typed on line 2 of
the face page of the application form
and the YES box must be marked. Email or other electronic applications
will not be accepted under this
announcement.
Specific supplementary instructions
for the PHS 398 application and budget
preparation for the NARCH program
may be obtained from the initiative
contacts listed under VII. Agency
Contacts, and will be posted at: https://
www.ihs.gov/MedicalPrograms/
Research/narch.cfm. There will be no
acknowledgment of receipt of the
application.
2. Content and Form of Application
Submission: A proposed NARCH may
include any or all of the following
components: student development
projects; faculty/researcher
development projects; research projects
(including pilot projects); and ‘‘core’’
administrative facilities.
The content of the application should
explain the components of the
application, and how they help meet the
purpose of the NARCH initiative. A
description should be provided of the
current state of the research and
research training enterprise at the
proposed NARCH and its institutional
and community partners, including
faculty/researcher and student profiles.
A clear statement should be presented
of the overall goals, specific measurable
objectives, and anticipated milestones.
These elements should be presented in
the context of needed improvements in
the partners’ organizational
infrastructure and environment for
research. Documentation should be
provided to establish that the researchintensive partner is an institution with
a record of conducting research into the
health of AI/ANs, and that it has a
demonstrated commitment to the
E:\FR\FM\24JAN1.SGM
24JAN1
jlentini on PROD1PC65 with NOTICES
4238
Federal Register / Vol. 73, No. 16 / Thursday, January 24, 2008 / Notices
special encouragement of, and
assistance to, AI/AN faculty/researchers,
students, investigators, and
communities for enhancing their
capacity to engage in biomedical,
behavioral and health services research.
Documentation about the nature of the
partnership itself should be included,
such as: the process to develop the
application and proposed NARCH itself,
the past and future efforts to increase
the capacity of the partners to improve
their partnership, and efforts to
contribute to the success of the NARCH.
A plan for assessment of the benefits
of the activities by the proposed NARCH
on specific, measurable outcomes
identified in the application should be
provided. IHS and NIGMS recognize
that Tribes, Tribally-based
organizations, and research-intensive
institutions are diverse in their
missions, their health and economic
status, and their cultures. Such an
assessment could include a self-study
by the proposed NARCH and its
partners, which focuses on fact-finding,
program evaluation, and
recommendations for improvement in
key areas.
Strategies for determining the initial
and ongoing success of their efforts for
organizational development should also
be presented. It is expected that each
proposed NARCH will develop its own
set of strategies that best match its
circumstances. Guidance and
suggestions for program evaluation of a
proposed NARCH can be obtained from
https://www.the-aps.org/education/
promote/promote.html.
Applications are strongly urged to
contact NARCH initiative staff at an
early stage to request the specific
supplementary instructions for the PHS
398 for the NARCH grants.
Supplementary instructions may be
obtained from the initiative contacts
listed under VII. Agency Contacts, and
will be posted at: https://www.ihs.gov/
MedicalPrograms/Research/narch.cfm.
If Student Development Projects are
proposed, the NARCH application
should describe new programs of
modifications or additions to existing
programs of the partners that encourage
and facilitate AI/AN students to enter,
advance, and remain in research careers.
Such projects might include, but are not
limited to, providing employment as
research assistants in research projects
of research-active mentors with an
explicit mentoring plan, providing other
mentoring with an explicit mentoring
plan, providing workshops to improve
technical or communication skills,
providing motivating seminars or
journal clubs highlighting problems of
interest to students, providing contact
VerDate Aug<31>2005
20:35 Jan 23, 2008
Jkt 214001
with role models, and providing
opportunities to travel to present results
at national scientific meetings. If
research mentorships or apprenticeships
are proposed, the application should
clearly document the experience,
proposed commitment, and quality of
the mentors in providing guidance and
advice to students (including
responsible conduct of research and
research integrity, teaching, and
protection of human subjects), and in
fostering the development of academic
and/or community based AI/AN
researchers.
The application should describe how
the development plans for the student
will meet both the individual’s
professional development goals, and
one purpose for the NARCH initiative:
to develop a cadre of AI/AN scientists
and health professionals. The
application must have an evaluation
plan for the project(s) that indicates the
anticipated outcomes relative to the
current baseline data. For example, one
outcome might be the improved
retention of AI/AN students in science
majors. The application should indicate
the anticipated (quantitative)
improvement relative to the current
retention rate.
A student in a NARCH Student
Development Project must be a full-time
or part-time student officially enrolled
in an educational program leading to an
undergraduate or graduate degree, or in
a post-doctoral educational program, or
(if well justified) in a late high school.
A helpful book about mentoring science
students is found at https://
book.nap.edu/catalog/5789.html.
If Faculty/Researcher Development
Projected are proposed, the NARCH
application should describe the need,
proposed activity, and anticipated
outcomes. Faculty/researcher
development projects might include, but
are not limited to, short-term mentored
research experiences in the lab of an
active NIH-extramurally-funded
researcher with an explicit mentoring
plan, long-term general mentoring under
an explicit mentoring plan, or
attendance at workshops or courses or
national meetings needed for acquiring
specific skills or methodologies needed
for prospective research. As with
student development projects, the
application should document the
experience, proposed commitment, and
quality of the mentors, teachers, or
experience in providing guidance and
advice to faculty/researchers, and in
fostering the development of academic
and community-based AI/AN research.
The application must also describe the
evaluation plan for the faculty/
researcher development project. The
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
application must clearly describe how
the development plans for faculty/
researchers will meet both the
individual’s professional development
goals, and two purposes of the NARCH
initiative:
• To develop a cadre of AI/AN
scientists and health professionals, and
• To enhance the partnership of the
proposed NARCH.
NARCH applications may include a
maximum of five (5) regular Research
Projects and a maximum of five (5) Pilot
Research Projects. Unlike regular
research projects, a pilot research
project is limited in scope and is not
expected to have preliminary data. It is
also limited to a budget of no more then
$50,000 direct costs per year for four
years. The pilot research project is
intended for faculty/researchers without
current federal research support.
Support for faculty/researchers
participating in pilot research projects is
preparatory to seeking more substantial
funding from NIH research grant
programs (e.g., Academic Research
Enhancement Award, K and R01
awards), as well as funding from other
agencies and private sources. Funds
received from the proposed NARCH to
support pilot research projects may not
be used to supplement ongoing research
projects. A NARCH application need not
include both research projects and pilot
research projects. Applications for only
pilot research projects or for only
research projects may be submitted.
Individual project investigators may
propose either a research project or a
pilot research project, but not both.
Each research project or pilot research
project should follow the instructions
provided in PHS 398 (Revised 9/2004,
Interim Revision 4/2006) for preparing
research grant applications. The
professional development goals must
clearly describe specific objectives and
milestones which should include, but
are not limited to, improving
competitiveness in acquiring grant
support. The applicant should described
how successful completion of the
proposed research project will improve
the research skills and will help develop
the students and faculty/researchers,
thus contributing to the overall goals
and specific measurable objectives of
the proposed NARCH.
Each research project or pilot research
project must follow the IHS policy
concerning Tribal approval, that all
research involving AI/AN Tribes be
approved by the Tribal governments
with jurisdiction. That is, each grantee
must include a resolution of approval
from the Tribal government(s), or (if
applicable) a letter of support signed by
the director of the eligible AI/AN
E:\FR\FM\24JAN1.SGM
24JAN1
Federal Register / Vol. 73, No. 16 / Thursday, January 24, 2008 / Notices
organization, or both (if applicable) for
projects that involve people or
community(ies) of an AI/AN Tribe, or
an eligible Tribal organization.
Research projects (including pilot
research projects) proposed under this
initiative must be in research areas
normally funded by any of the NIH or
other research agencies in the HHS.
Research projects addressing health
disparities and the health priorities of
the AI/AN partner are especially
encouraged.
A listing of grants recently funded by
NIH may be found at Computer
Retrieval of Information on Scientific
Projects (CRISP), a searchable database
of Federally funded biomedical research
projects conducted at universities,
hospitals, and other research
institutions. It may be accessed at
https://ott.od.nih.gov/crisp.html.
The following agencies, institutes,
offices and centers have stated
particular interests in supporting
research under the NARCH Program as
follows:
National Institute of Dental and
Craniofacial Research (NIDCR)
jlentini on PROD1PC65 with NOTICES
Oral Health Research
NIDCR is committed to reducing the
disproportionate burden of oral diseases
experienced by AI/ANs. The focus of
NIDCR’s health disparities research is
on improving oral health status and
quality of life by understanding and
addressing oral diseases that are
prevalent in AI/AN communities,
specifically caries (including early
childhood caries), oral and pharyngeal
cancer, and periodontal disease.
Interdisciplinary research teams and the
full participation of communities are
viewed by NIDCR as essential
components of any health disparities
research.
Data that document oral disease
prevalence are readily available for
some populations, but not for others.
Homogeneity in subgroups of
populations cannot be assumed. For
instance, there are national data for
Mexican Americans, but not for the
numerous other Hispanic subgroups.
Similarly, data regarding the oral health
status of various AI/AN Tribes are
unavailable. Moreover, available data
provide little insight into the etiology or
determinants of oral disease and oral
health. The paucity of quality data and
conceptual models concerning the broad
array of potential determinants and riskfactors inhibits progress toward
preventing disease, and improving oral
health status and quality of life. The
NIDCR invites applications that, in
preparation for intervention research,
VerDate Aug<31>2005
20:35 Jan 23, 2008
Jkt 214001
explore the complex array of social,
behavioral, psychological, contextual,
environmental and biological factors
and their interactions that may
contribute to oral health disparities
within AI/AN communities. Including
oral health status measures within
broader epidemiologic studies is
encouraged. However, applications that
are limited to the assessment of disease
prevalence and that explore a very
limited range of potential determinants
will be considered non-responsive.
The NIDCR has particular interest in
intervention research that will provide
clinically meaningful outcomes and
essential information needed to inform
clinical practice, public health policy,
health care provision, community and/
or individual action. Intervention
studies that are grounded in theory are
needed. Both basic and applied
intervention research applications are
invited. Studies may need to intervene
at multiple levels within communities.
The NIDCR encourages the use of the
strongest research design possible and
recognizes that not all intervention
research is amenable to randomized
clinical trials. Examples of health
disparities intervention research of
interest to the NIDCR includes but are
not limited to:
• Effectiveness studies that tailor/
target preventive approaches to
communities/individuals;
• Research that intervenes in novel
ways on macro- or intermediate level
determinants of oral health status;
• Health services research that
explores alternative approaches to
delivering preventive oral health care;
• Studies that intervene on common
risk factors or that take a systems
approach;
• Studies that explore multifaceted
strategies to intervene at several levels
within society;
• Dissemination and implementation
research at multiple organizational
levels; and
• Research that uses appropriate
technology for translation,
implementation, adoption, adherence
and acceptance of oral disease
prevention programs in defined
populations, clinics, and communities.
Intervention research should be
reasonably applicable to a specific AI/
AN population. To facilitate adequate
enrollment and generalizability,
intervention studies may need to be
conducted at multiple sites. While small
clinical trials are not permitted, studies
may be conducted at a single site if
enrollment is adequate and if sufficient
numbers of participants are available to
allow extrapolation of clinically
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
4239
meaningful results to the specific AI/AN
population of interest.
Pilot research projects that are
designed to lead to larger research
projects funded as part of a center or as
free-standing NIH grants may be
proposed.
For additional information about oral
health research contact:
Ruth Nowjack-Raymer, M.P.H., Ph.D.,
Director, Health Disparities Research
Program, National Institute of Dental
and Craniofacial Research, 45 Center
Drive, Room 4AS–43F, Bethesda, MD
20892–6401, Phone: (301) 594–5394,
Fax: (301) 480–8322, E-mail:
nowjackr@mail.nih.gov.
National Institute on Drug Abuse
(NIDA)
Neuroscience and Drug Abuse Research
AI/ANs demonstrate higher rates of
drug abuse, particularly
methamphetamine, tobacco and alcohol
abuse, relative to other racial subgroups.
According to 2002–2006 National
Survey on Drug Use and Health
(NSDUH) data, AI/AN past year
methamphetamine use was 1.4%
compared to 0.1% for African
Americans, 0.6% for Hispanics or
Latinos and 0.7% for Whites. Prevalence
of use is high in both men and women.
Drug abuse patterns among AI/AN are
complex and can vary by factors such as
Tribe and geographic location. While
some datasets are available that can
provide general epidemiological data
regarding use and abuse rates in this
group, data are needed that better clarify
where use rates are highest, among
which Tribes, age and gender groups
and the factors that predict drug abuse
in these locales and groups. These data
will assist in developing more targeted
interventions and in identifying
mechanisms related to drug abuse
which can then serve as focal points for
intervention.
In addition to scarce data on patterns
of use, limited data are available
assessing drug abuse prevention and
treatment interventions for AI/AN. The
matrix model has been proposed in
particular to address methamphetamine
abuse, but few data are available to
assess the efficacy of this approach with
this population. Several preventive
interventions have been designed
particularly for this population and
results from them indicate their value,
but more research is needed to clarify
why these sometimes don’t work in
expected ways and whether the
interventions that are being used but
have not been evaluated are working to
reduce drug use.
E:\FR\FM\24JAN1.SGM
24JAN1
4240
Federal Register / Vol. 73, No. 16 / Thursday, January 24, 2008 / Notices
The NIDA is committed to reducing
health disparities in drug abuse and
related health and social consequences
among AI/AN. Further, the Institute
supports methodologies required by the
NARCH, expecting that studies be
developed and implemented using
community participatory approaches.
Research topics of interest include but
are not limited to:
• Studies that explore a range of
behavioral, cultural, environmental and
individual factors that contribute to
drug abuse;
• Studies that explore the
consequences of drug abuse among AI/
AN;
• Studies that consider the full
context of drug abuse, including
poverty, family factors, school factors,
intergenerational trauma, etc.;
• Studies that explore the role of
traditional practices and spirituality in
protecting against drug abuse;
• Studies that explore other factors
that protect against use in those groups
for whom use rates are lower;
• Studies that explore the efficacy
and/or effectiveness of culturally
relevant preventive interventions;
• Studies that explore the efficacy
and/or effectiveness of culturally
relevant treatment interventions;
• Studies that assess factors related to
service utilization, including use rates
and access to services, either in
reservation or urban settings; and
• Studies that explore the
organization, management and delivery
of interventions.
For additional information about
neuroscience or drug abuse research
contact: Kathy Etz, PhD, National
Institute on Drug Abuse, 6001 Executive
Blvd., Room 5153 MSC 9589, Bethesda,
MD 20852, Phone: (301) 402–1749, Fax:
(301) 480–2543.
National Cancer Institute (NCI)
jlentini on PROD1PC65 with NOTICES
Tobacco Control Research
AI/ANs have been documented to
have the highest smoking rate of any
major racial/ethnic group in the U.S.
According to the 2005 National Health
Interview Survey of adults 18 and over,
32% of AI/AN are current smokers,
compared with 21.9% of non-Hispanic
whites, 21.5% of non-Hispanic Blacks,
13.3% of Asians and 16.2% of
Hispanics. Prevalence of smoking is
high among both men (37.5%) and
women (26.8%).1 A similar pattern can
be seen among youth, where AI/AN
youth have substantially higher smoking
prevalence (23.1%) than non-Hispanic
whites (14.9%), Hispanics (9.3%), nonHispanics blacks (6.5%), and Asians
(4.3%), according to data from the
VerDate Aug<31>2005
20:35 Jan 23, 2008
Jkt 214001
National Survey on Drug Use and
Health. These data also show that nonsmoking AI/AN youth demonstrated
higher susceptibility to experimenting
with smoking than most other racial/
ethnic groups.2
At the same time, however, tobacco
use patterns among the AI/AN
population are complex and can vary
substantially among subgroups of this
population. Smoking rates among AI/
ANs vary widely by region, being
highest in the northwestern United
States, in Canada, and in Alaska.
Additionally, use of smokeless tobacco
is higher among AI/AN adults compared
with other racial/ethnic groups. Some
studies have found particularly high
rates of smokeless tobacco use (greater
than 50%) among AN populations,
including pregnant women, due to the
use of Iqmik, a traditional form of
smokeless tobacco.3
Understanding tobacco use among
Native American populations is also
complicated by the fact that tobacco has
had a substantial role in Native
American culture and tradition.
Historically, tobacco has been used in
medicinal and healing rituals and in
ceremonial and religious practices. It is
important to distinguish the traditional,
ceremonial uses of tobacco, which are
limited to specific occasions, from
addictive use of tobacco products.
However, the relationship between
these different contexts of tobacco use
and their impact on behavior has not
received sufficient scientific study.
Moreover, limited data are available
on the effectiveness of tobacco use
cessation interventions targeted to AI/
ANs. Preliminary focus group studies
suggest that Native American smokers
are more likely to have negative
attitudes towards pharmacotherapies,
such as concerns about side effects and
lack of trust in conventional medicine.4
Thus, there is a need to develop
culturally-appropriate interventions
targeted to this population.
The NCI Tobacco Control Research
Branch is committed to supporting
transdisciplinary research aimed at
reducing disparities in tobacco use and
related health outcomes. The NARCH
provides a unique mechanism to
support collaborative research involving
researchers from multiple disciplines to
address a complex scientific and public
health challenge.
Sample research areas of interest
include but are not limited to the
following:
• Studies to understand the role of a
range of behavioral, cultural and
environmental factors that lead to
initiation of tobacco use among AI/AN
populations.
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
• Development and evaluation of
culturally appropriate interventions for
tobacco use prevention and cessation
targeted to AI/AN populations;
• Studies of how tobacco related
attitudes and behaviors in youth and
adults are influenced by ceremonial
tobacco use and other cultural factors;
• Studies of tobacco use behavior in
relation to different products, including
dual use of cigarettes and smokeless
tobacco;
• Research on the characteristics, use
and health effects of traditional tobacco
products, such as Iqmik;
• Research to understand disparities
in tobacco use within AI/AN
populations given substantial variations
by region and other factors; and
• Studies to identify and address
barriers to treatment among AI/ANs.
References
1. Tobacco Use Among Adults—
United States, 2005. MMWR. October
27, 2006; 55: 1145–1148.
2. Racial/Ethnic Differences Among
Youths in Cigarette Smoking and
Susceptibility to Start Smoking—United
States, 2002–2004. MMWR. December 1,
2006; 55; 1275 1277.
3. Renner CC, Pattern CA, Day GE,
Enoch CC, Schroeder DR, Offord KP,
Hurt RD, Gasheen A, Gill L. Tobacco use
during pregnancy among Alaska Natives
in western Alaska. Alaska Med.
2005;47:12–6.
4. Burgess D, Fu SS, Joseph AM,
Hatsukami DK, Solomon J, van Ryn M.
Beliefs and experiences regarding
smoking cessation among American
Indians. Nicotine Tob Res. 2007; 9
Suppl 1: S19–28.
For additional information about NCI
tobacco research contact: Mark
Parascandola, PhD, Epidemiologist,
Tobacco Control Research Branch,
National Cancer Institute, 6130
Executive Blvd. MSC 7337, Executive
Plaza North, Room 4039, Bethesda, MD
20892, Phone: 301–451–4587, Fax: 301–
496–8675, paramark@mail.nih.gov.
National Heart, Lung, and Blood
Institute (NHLBI)
Cardiovascular and Respiratory
Research
The NHLBI has a strong history of
supporting research to document and
intervene on health disparities among
AI/ANs, including the Strong Heart
Study, Pathways, Genetics of Coronary
Artery Disease in Alaska Natives
(GOCADAN), the Stop Atherosclerosis
in Native Diabetics Study (SANDS), and
Community-Responsive Interventions to
Reduce Cardiovascular Risks in AI/ANs.
The Strong Heart Study showed that
many AI/AN communities bear a heavy
E:\FR\FM\24JAN1.SGM
24JAN1
jlentini on PROD1PC65 with NOTICES
Federal Register / Vol. 73, No. 16 / Thursday, January 24, 2008 / Notices
burden of cardiovascular disease (CVD)
and cardiovascular risk factors (e.g.,
obesity, diabetes) that could be reduced
through effective interventions on
modifiable risk factors. The high burden
of disease will worsen unless behaviors
and lifestyles affecting CVD risk can be
changed. Prevalence of obesity in AI/AN
communities is about 50% higher than
in the U.S. general population in which
obesity is often described as being of
epidemic proportions. In some AI/AN
communities, cigarette smoking,
sedentary lifestyle, and stress augment
the adverse effects of obesity. AI/AN are
particularly vulnerable to Type II
diabetes, a problem exacerbated by high
rates of obesity. Diabetes prevalence is
3–20 fold higher among AI/AN than in
the general U.S. population. It is an
important cause of coronary heart
disease, cardiomyopathy, end-stage
renal disease, non-traumatic
amputation, and vision impairment.
Lipid abnormalities also are common in
Type II diabetics,, particularly high
triglycerides and low HDL-cholesterol
levels. Dyslipidemia and blood pressure
can be improved by appropriate changes
in diet and by increased exercise. CVD
risk is also substantially improved by
smoking cessation. In addition,
attention to high stress levels, untreated
sleep disordered breathing, short sleep
duration, and depression may be
warranted because of evidence that they
may influence the health behaviors of
interest. For example, poorer diet,
higher smoking rates, and physical
inactivity are more prominent in those
with high stress, sleep disorders, or
depression. These psychosocial factors
also are associated with CVD
progression in observational
epidemiologic studies, and there is
evidence from smaller clinical studies
they may affect mechanisms leading to
CVD. NHLBI is interested in supporting
research in AI/AN communities that
promote the adoption of healthy
lifestyles and/or improve behaviors
related to cardiovascular (CV) risk, such
as weight reduction, regular physical
activity, and smoking cessation. These
behaviors and lifestyles are known to
affect biological cardiovascular risk
factors, such as hypertension,
dyslipidemia, obesity, glucose
intolerance, and diabetes. In addition,
control of these risk factors by
guideline-based use of antihypertensive,
lipid lowering, and hypoglycemic drugs
can reduce their adverse consequences.
However, these pharmacological
interventions are often suboptimally
utilized in AI/AN communities. The
NHLBI is interested in reducing
cardiovascular disease mortality and
VerDate Aug<31>2005
20:35 Jan 23, 2008
Jkt 214001
morbidity in AI/AN, whether by
lifestyle changes, drug interventions, or
combinations thereof.
Lifestyles characterized by sleeping
less than 5–6 hours per night are
associated with increased risk of CVD,
obesity, and diabetes. Insufficient sleep
as a behavioral stressor is associated
with risk of new onset substance abuse
and relapse, and depression risk and
relapse. Intervention studies to assess
the efficacy of improving sleep as part
of a healthy lifestyle or assessing how
improving sleep disorders could
improve CVD outcomes would be of
interest to NHLBI.
AI/AN also have been documented to
exhibit high rates of chronic respiratory
disease. AI/AN adults have the highest
asthma rate among single-race groups.
Recent evidence suggests that 11.6
percent of AI/AN suffer from asthma.
This is significantly higher than the
national average of 7.5 percent, and
much higher than every other single
racial or ethnic group. Chronic
obstructive pulmonary disease (COPD),
which includes emphysema and chronic
bronchitis, is the eighth leading cause of
death from chronic disease for AI/AN
men and the sixth leading cause of
death for women. AI/AN have the
second highest rates of cystic fibrosis
following whites. One in 10,500 AI/AN
has cystic fibrosis compared with one in
3,500 whites. Pueblo Indians and Zuni
Indians have higher incidence than
among other AI/AN Tribes. Sleep
disordered breathing appears to be 30–
60% more common among American
Indians than other racial and ethnic
groups. NHLBI is interested in
supporting research in AI/AN
communities that includes studies of
approaches to improve clinical delivery
of efficacious treatments of chronic lung
disease and their risk factors, improved
methods of chronic lung disease selfmanagement, studies to promote or
maintain respiratory health or improved
methods of rehabilitation for diseases of
the lungs and airways, such as asthma,
emphysema, cystic fibrosis; sleep
disordered breathing, occupational lung
diseases, pulmonary vascular disease or
pulmonary complications of Acquired
Immune Deficiency Syndrome (AIDS).
In addition to these areas of research,
the NHLBI recognizes a unique and
compelling need to promote diversity in
the biomedical, behavioral, clinical, and
social sciences research workforce. The
NHLBI expects efforts to diversify the
workforce to lead to:
• The recruitment of the most
talented researchers from all groups;
• An improvement in the quality of
the educational and training
environment;
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
4241
• A more balanced perspective in the
determination of research priorities;
• A improved capacity to recruit
subjects from diverse backgrounds into
clinical research protocols; and
• An improved capacity to address
and eliminate health disparities.
For more information, please contact:
Jared B. Jobe, Ph.D. (Cherokee), Program
Director, Clinical Applications and
Prevention Branch, Division of
Prevention and Population Sciences,
National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Suite
10018, MSC 7936, Bethesda, Maryland
20892–7936 (20817 express), Phone:
(301) 435–0407, Fax: (301) 480–5158,
JobeJ@mail.nih.gov (e-mail).
National Institute of Arthritis and
Musculoskeletal and Skin Diseases
(NIAMS)
Research in Osteoporosis and Other
Bone Diseases, Osteoarthritis,
Rheumatoid Arthritis and Skin Disease
Within the NIAMS Mission
The NIAMS supports efforts to
conduct research into the causes,
treatment, and prevention of arthritis
and musculoskeletal and skin diseases;
the training of basic and clinical
scientists to carry out this research; and
the dissemination of research progress
to improve the public health. Goals
specific to the AI/AN communities
involve research addressing the training
of underrepresented minority AI/AN
researchers and ensuring inclusion of
Native communities in clinical research
studies. NIAMS actively monitors the
inclusion of minority populations in
clinical research and will highlight any
grants that specifically target AI/AN
populations. The mission of the NIAMS
is to support research into the causes,
treatment, and prevention of arthritis
and musculoskeletal and skin diseases,
the training of basic and clinical
scientists to carry out this research, and
the dissemination of information on
research progress in these diseases.
Studies in these mission areas as they
relate to the AI/AN population may be
proposed.
For additional information about
research in these areas contact:
Madeline Turkeltaub, CRNP, Ph.D.,
Deputy Director, Extramural Program,
National Institute of Arthritis and
Musculoskeletal and Skin Diseases,
6701 Democracy Blvd., Suite 800,
Bethesda, MD 20912, Phone: (301) 594–
2463, Fax: (301) 480–4543, E-mail:
mturkeltaub@mail.nih.gov.
E:\FR\FM\24JAN1.SGM
24JAN1
4242
Federal Register / Vol. 73, No. 16 / Thursday, January 24, 2008 / Notices
National Center for Complementary
and Alternative Medicine (NCCAM)
jlentini on PROD1PC65 with NOTICES
Research on Traditional Healing
Practices
Many AI/AN communities use
traditional healing practices to prevent
and/or treat diseases and to maintain
health. NCCAM is interested in
supporting research on traditional
healing practices with these goals in
mind. NCCAM is also interested in
research on the safe and effective
integration of conventional care with
traditional healing practices for AI/AN
communities. The methodological
feasibility for integration has yet to be
addressed for many traditional healing
practices. Consequently, NCCAM is
interested in supporting developmental
studies to identify and address difficult
methodological and design issues
particular to traditional healing
practices, as well as to allow for the
development of contextually and
culturally sensitive research mirroring
the values of AI/AN communities.
Examples of study areas of interest
include, but are not limited to:
• Qualitative research to characterize
and document healing practices and
diagnostic approaches of indigenous
peoples, and study the feasibility of
research on those practices and
approaches in future clinical studies;
• Observational studies to explore
patient and care provider preferences,
beliefs, attitudes, and patient-provider
interactions;
• Case-control, observational, and
other studies to understand traditional
healing strategies from multiples
perspectives, including: (a) Optimal
dosing, duration, and frequency of
treatment; (b) type of treatment; (c)
examinations of different healing
practices to treat a particular disease/
condition; (d) comparisons of complex
versus simple interventions; (e)
evaluation of adherence among patient
populations to interventions with
varying levels of complexity; and (f)
examination of potentially important
individual differences that mediate or
moderate treatment outcome;
• Studies to determine if traditional
healing practices can be translated into
a broader clinical setting, in terms of:
Reliability, responsiveness, and utility;
assessment procedures, instruments,
and tools in psychosocial, functional,
and physiological domains;
• Studies to construct and validate
culturally sensitive data collection
instruments; to design and pilot
outcome measures consistent with the
tenets of traditional, indigenous systems
of medicine and comparisons of these
VerDate Aug<31>2005
20:35 Jan 23, 2008
Jkt 214001
outcome measures to those commonly
used by conventional biomedicine; and
• Health services research of
established AI/AN traditional healing
practices to explore the factors that
influence access to and use of such
therapies; the nature, cost effectiveness,
and quality of such care; and ultimately
the effects on health and well-being.
For additional information on
NCCAM-supported research topics,
contact: Peter J. Kozel, Ph.D., National
Center of Complementary and
Alternative Medicine, 6707 Democracy
Boulevard, Suite 401, MSC 5475,
Bethesda, MD 20892–5475, Phone: (301)
496–8004, Fax: (301) 480–3621,
kozelp@mail.nih.gov.
Office of Research on Women’s Health
(ORWH)
Women’s Health Research
The ORWH at the NIH supports
research related to women’s health and
the study of sex and gender differences.
Detailed information about the NIH
Research Priorities for Women’s Health,
can be found at https://orwh.od.nih.gov/
research.html.
For additional information on
women’s health research, contact: Lisa
Begg, DrPH., RN, Director of Research
Programs, NIH Office of Research on
Women’s Health, 6707 Democracy
Blvd., Suite 400, Bethesda, MD 20892–
5484, Phone: (301) 496–7853, Fax: (301)
402–1798, beggl@od.nih.gov.
National Institute of Mental Health
(NIMH)
Research projects aimed at
understanding the burden, treatment or
prevention of mental disorders and
Human Immunodeficiency Virus (HIV)/
AIDS in AI/AN populations.
Indigenous people in the United
States are disproportionately affected by
mental illness and HIV infection, as are
the larger racial and ethnic populations
such as African Americans and Latinos.
AI/ANs are highly underrepresented in
the physician workforce and as
researchers in health research in
general, numbering fewer than one
hundred.
Other factors that contribute to
disparities that affect these communities
include geographic isolation, poor
access to health services,
underutilization of health services,
insufficient screening and partner
management services, unique social
norms, stigma and gender dynamics.
Research is needed to identify and
address the impact as well as the
specific and unique aspects of mental
disorders and HIV infection upon
Native American communities. A
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
critical component of response to
mental health and HIV infection in
Native American communities will be to
identify, train, mentor, and develop
Native American investigators. Towards
these ends, a promising model is
community-based participatory research
together with community capacity
building.
Some NIMH research areas that can
contribute to scientific knowledge about
mental health and HIV interventions in
Native Americans includes:
• Research methods/community
assessment;
• Studies of the impact of traumatic
stressors, studies of patient, provider
and contextual factors;
• Intervention research to evaluate
the effectiveness of pharmacologic,
psychosocial (psychotherapeutic and
behavioral), somatic, rehabilitative and
combination interventions on mental
and behavior disorders-including acute
and longer-term therapeutic effects on
functioning for children, adolescents,
and adults;
• Studies of services organization,
delivery (process and receipt of care),
and related health economics at the
individual, clinical, program,
community and systems levels in
specialty mental health, general health,
and other delivery settings (such as the
workplace);
• Interventions to improve the quality
and outcomes of care (including
diagnostic, treatment, preventive, and
rehabilitation services);
• Studies to enhance the research
infrastructure for conducting services
research; studies of clinical
epidemiology of mental disorders across
all clinical and service settings;
• Scientifically rigorous investigation
of culturally appropriate prevention and
control strategies;
• Adaptation, evaluation, safety and
costs of proven interventions;
• Dissemination and implementation
strategies; and,
• The role of community stakeholders
in the research process, especially
readiness for change.
For additional information on NIMH
NonAIDS Applications contact: Carmen
P. Moten, Ph.D., Chief, Primary Care,
Socio Cultural and Disparities Research
Programs, Division of Services and
Intervention Research, National Institute
of Mental Health, 6001 Executive
Boulevard, Room 7131, MSC 9631,
Bethesda, MD 20892–9631, Telephone:
(301) 443–3725, FAX: (301) 443–4045,
E-mail: cmoten@mail.nih.gov.
For additional information on NIMH
HIV/AIDS-related applications contact:
David M. Stoff, Ph.D., Chief: HIV/AIDS
Neuropsychiatry Program, AIDS
E:\FR\FM\24JAN1.SGM
24JAN1
Federal Register / Vol. 73, No. 16 / Thursday, January 24, 2008 / Notices
Research Training and HIV/AIDS,
Disparities Program, Division of AIDS
and Health and Behavior Research,
National Institute of Mental Health,
6001 Executive Boulevard, Room 6210,
MSC 9619, Bethesda, MD 20892–9619,
Telephone: (301) 443–4625, FAX: (301)
443–9719, E-mail: dstoff@mai1.nih.gov.
National Library of Medicine (NLM)
Biomedical Informatics and Knowledge
Management
NLM supports research into how
computers and networks can best be
used to capture, represent, store,
retrieve, manipulate, manage, and
disseminate information for use in
health care and public health, health
education, and biomedical research.
These informatics research projects
must be user-centered, aimed at meeting
needs of health care providers,
consumers, students, researchers, and
policy makers. To be user centered,
information systems must be usable and
useful, and information must be
understandable to the audience for
whom it is intended, accurate, and
timely. The knowledge people need to
participate in their own health care and
the care of others is complex and comes
from many sources. Important research
questions remain to be answered about
the most effective ways to bring these
different sources together when and
where they are needed. Informatics is by
nature an interdisciplinary field, and
the training of researchers for
informatics careers involves coursework
in the concepts and practices of
information and computer science as
well as in domains of health and
biomedicine. NLM offers training
programs at 18 academic organizations,
for pre and post-doctoral trainees who
wish to pursue a career in informatics.
Many of these organizations offer
special short-term traineeships of three
months that provide a trainee with an
introduction to informatics research.
For additional information about
NLM programs contact: Valerie
Florance, Ph.D., Deputy Director, NLM
Extramural Programs, Rockledge 1,
Suite 301, 6705 Rockledge Drive,
Bethesda, MD 20892, Phone: (301) 594–
4882, Fax: (301) 402–2952, Web site:
https://www.nlm.nih.gov/ep NLM/NIH/
DHHS.
jlentini on PROD1PC65 with NOTICES
National Institute of Biomedical
Imaging and Bioengineering (NIBIB )
Research in Technology for Health
The National Institute of Biomedical
Imaging and Bioengineering (NIBIB) is
committed to reducing health
disparities through the development of
new and affordable biomedical
VerDate Aug<31>2005
20:35 Jan 23, 2008
Jkt 214001
technologies. To this end, the NIBIB is
interested in supporting the translation
of biomedical technologies that target
the health needs of AI/AN communities.
Specifically, the NIBIB is interested in
supporting the development of
technologies that have broad therapeutic
and interventional applications as well
as technologies that complement
technology development in all program
areas of the NIBIB, https://
www.nibib.nih.gov/Research/
ProgramAreas.
For additional information about
NIBIB programs contact: John W. Haller,
PhD., National Institute of Biomedical
Imaging and Bioengineering, NIH/
DHHS, 6707 Democracy Blvd. Suite 200,
Bethesda, MD 20892–5649, E-mail:
hallerj@mail.nih.gov, Phone: (301) 451–
4780, Fax: (301) 480–1614.
National Eye Institute (NEI)
Vision Research
The NEI supports research and health
information dissemination with the goal
of protecting and prolonging the vision
of the American people. Examples of
such activity that may be of interest
include, but are not limited to:
• Epidemiological studies to
determine the prevalence and possible
risk factors of eye diseases and disorders
among AI/AN populations;
• Basic research studies into the
causes and mechanisms of eye diseases
and visual impairments in AI/AN,
research into disparities in access to
ophthalmic/optometric health services;
and,
• Development and evaluation of
culturally appropriate health education
and intervention.
For additional information on vision
research topics contact: Jerome R.
Wujek, Ph.D., National Eye Institute,
2020 Vision Place, Bethesda, MD
20892–3655, Phone: (301) 451–2020,
Fax: (301) 402–0528, E-mail:
wujekjer@nei.nih.gov.
The omission above of any NIH
institute, center, office, or research area
should not be taken as a lack of
availability of support for proiects in
those areas. NARCH is an NIH-wide
partnership, led at NIH by the National
Institute of General Medical Sciences
(NIGMS). General research priorities for
all of the individual NIH Institutes,
Centers, Divisions and Offices can be
found on their respective Web sites at:
https://www.nih.gov/icd/.
However, applicants and potential
academic partners are reminded that
that the NARCH program is focused on
the research needs of the Tribes and not
those of the Federal or academic
partners.
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
4243
Public Policy Requirements: All
Federal-wide public policies apply to
IHS grants with exception of Lobbying
and Discrimination public policy.
3. Submission Dates and Times:
A. Letter of Intent Deadline: March 15,
2008.
Prospective applicants are asked to
submit a letter of intent that includes
the title of the new project(s) proposed,
the name, address, and telephone
number of the project Principal
Investigator(s), the identities of the
partners and of key personnel, and the
number and title of this RFA. The letter
of intent should be received before 5
p.m. Eastem Standard Time on March
15, 2008, by Mushtaq A. Khan, D.V.M.,
Ph.D., Chief, Digestive and Respiratory
Sciences IRGs, Center for Scientific
Review, MSC 7818, Room 2176; 6701
Rockledge Drive; Bethesda, MD 20892
(20817 for Fed Ex) Phone: (301) 435–
1778; Fax (301) 451–2043; E-Mail:
KHANM@CSR.NIH.GOV.
Letters may be submitted by mail, fax
or e-mail. Although a letter of intent is
not required, is not binding, and does
not enter into the review of a
subsequent application, the information
that it contains allows the IHS and NIH
Center for Scientific Review (CSR) staffs
to estimate the potential review
workload and avoid conflict of interest
in the review.
B. Application Deadline: May 16,
2008.
The applications must be received
before 5 p.m. Eastern Standard Time on
May 16, 2009 at the Center for Scientific
Review (CSR, National Institutes of
Health, 6701 Rockledge Drive, Room
6160—MSC 7892, Bethesda, MD 20892–
7720, Bethesda, MD 20817 (for express
or courier service). Telephone: (301)
435–0715.) and at the IHS Division of
Grants Operations (DGO, Indian Health
Service, Reyes Building, 801 Thompson
Avenue, TMP Suite 360, Rockville, MD
20852–1627 [zip code is unchanged for
express/courier services], Telephone:
(301) 443–5204). Applications received
after this date will be returned to the
applicant. Competing applications not
meeting the deadline date specified in
the announcement are considered late
applications and will not be considered
for funding under this announcement.
The CSR will not accept any application
in response to this RFA that is
essentially the same as one currently
pending initial review, unless the
applicant withdraws the pending
application. The CSR will not accept
any application that is essentially the
same as one already reviewed. This does
not preclude the submission of
substantial revisions of applications
already reviewed, but such applications
E:\FR\FM\24JAN1.SGM
24JAN1
jlentini on PROD1PC65 with NOTICES
4244
Federal Register / Vol. 73, No. 16 / Thursday, January 24, 2008 / Notices
must include an introductory letter
addressing the previous critique.
4. Intergovernmental Review: This
funding opportunity is not subject to
Executive Order 12372,
‘‘Intergovernmental Review of Federal
Programs.’’ A State approval is not
required.
5. Funding Restrictions:
• Pre-award costs are allowable
pending prior approval from the
awarding agency. However, in
accordance with 45 CFR Part 74 all preaward costs are incurred at the
recipient’s risk. The awarding office is
under no obligation to reimburse such
costs if for any reason the applicant
does not receive an award or if the
award to the recipient is less than
anticipated.
• The available funds are inclusive of
direct and appropriate indirect costs.
• Only one grant/cooperative
agreement will be awarded per
applicant under this announcement. .
• IHS will not acknowledge receipt of
applications. .
• Grantees are allowed a reasonable
period of time in which to submit
required financial and performance
reports. Failure to submit required
reports within the time allowed may
result in suspension or termination of
an active grant, withholding of
additional awards for the project, or
other enforcement actions such as
withholding of payments or converting
to the reimbursement method of
payment. Continued failure to submit
required reports may result in the
imposition of special award provisions,
or cause other eligible projects or
activities involving that grantee
organization, or the individual
responsible for the delinquency to not
be funded. Failure to obtain prior
approval for change in Scope, Principal
Investigator, Grantee Institutions,
Successor in Interest, or Recipient
Institute Name, undertaking any
activities disapproved or restricted as a
condition of the award, may result in
fund restrictions.
6. Other Submission Requirements:
Each submitted research project
(including pilot research projects)
should be budgeted so that it could
stand on its own. That is, each project
should be fundable under its own
budget so that it could be completed
even if the rest of the NARCH is not
funded. All things vital to each project
should be included in the budget of that
project and not included in the core.
The 49 NARCH core should include
only administrative, training or other
items that are non-essential to the
research projects. Each subcontractor
participating in each project should
VerDate Aug<31>2005
20:35 Jan 23, 2008
Jkt 214001
submit its budget as part of that project’s
budget, using appropriate form pages
from the PHS 398. Each project
submission should include a set of
budget pages from each of the
institutional partners participating in
that project. Each research project
budget should explicitly include that
portion of the grantee’s indirect costs
that are associated with activities under
that project.
Submit a typed and signed original
application, including the Checklist,
and one single-sided photocopy of the
entire application (including
Appendices and supporting documents)
in one package to: Division of Grants
Operations, Indian Health Service,
Reyes Building, 801 Thompson Avenue,
TMP Suite 360, Rockville, MD 20852–
1627 (zip code is unchanged for
express/courier services), Telephone:
(301) 443–5204.
At the time of submission, applicants
must also send four additional singlesided photocopied and signed
applications, including the Checklist,
Appendices, and supporting
documentation to: Center for Scientific
Review, National Institutes of Health,
6701 Rockledge Drive, Room 6160–MSC
7892, Bethesda, MD 20892–7720,
Bethesda, MD 20817 (for express or
courier service). Telephone: (301) 435–
0715. The Center for Scientific Review
no longer accepts hand delivered
applications. E-mail or other electronic
applications will not be accepted under
this announcement.
Specific supplementary instructions
for the PHS 398 application and budget
preparation for the NARCH program
may be obtained from the initiative
contacts listed under VII. Agency
Contacts, and will be posted at https://
www.ihs.gov/MedicalPrograms/
Research/narch.cfm.
DUNS Number
Applicants are required to have a Dun
and Bradstreet (DUNS) number to apply
for a grant or cooperative agreement
from the Federal Government. The
DUNS number is a nine-digit
identification number, which uniquely
identifies business entities. Obtaining a
DUNS number is easy and there is no
charge. To obtain a DUNS number,
access https://
www.dunandbradstreet.com or call
1–866–705–5711. Interested parties may
wish to obtain their DUNS number by
phone to expedite the process.
A DUNS number is required before
Central Contractor Registry (CCR)
registration can be completed. Many
organizations may already have a DUNS
number. Please use the number listed
above to investigate whether or not your
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
organization has a DUNS number.
Registration with the CCR is free of
charge.
Applicants may register by calling
1–888–227–2423. Please review and
complete the CCR Registration
Worksheet located at https://
www.grants.gov/CCRRegister.
More detailed information regarding
these registration processes can be
found at https://www.grants.gov.
Application Review Information
Upon receipt, IHS and NIH staff will
administratively review applications for
completeness and responsiveness.
Applications that are incomplete, nonresponsive to this RFA, not from
existing NARCH programs, or do not
follow the guidelines of the PHS form
398 (revised 9/2004) or of the
supplementary instructions for NARCH
grants (available at: https://www.ihs.gov/
MedicalPrograms/Research/narch.cfm),
may be returned to the applicant
without further consideration.
Applications will be evaluated in
accordance with the criteria stated
below for scientific and technical merit
by appropriate peer review groups
convened by the CSR. The National
Advisory General Medical Sciences
Council will conduct the second level of
review.
Criteria
Priorities for funding will be based on
the scientific and technical merit of the
application, the assessed potential of
investigators in the developmental
stages of their careers, and the
likelihood that the proposed project(s)
can further the purposes of the NARCH
initiative. Awards will be made only to
organizations with financial
management systems and management
capabilities that are acceptable under
HHS policy. Awards will be
administered under the HHS Grants
Policy Statement, January 2007.
A. Review of Student and Faculty/
Researcher Development Plans: The
anticipated effectiveness of the
proposed NARCH in making a
difference relative to the current baseline data (based in part on previous
experience of the NARCH) will be
assessed. Factors to be considered
include:
• The appropriateness of the content,
phasing, quality, and duration of the
student or faculty/researcher
development plans in the NARCH
application to achieve the scientific
development of the faculty/researcher,
post-doctoral, pre-doctoral,
undergraduate, and (if well justified)
high school students; and
E:\FR\FM\24JAN1.SGM
24JAN1
jlentini on PROD1PC65 with NOTICES
Federal Register / Vol. 73, No. 16 / Thursday, January 24, 2008 / Notices
• The research experience and
expertise, proposed commitment, and
quality of the mentoring plan and of
individual mentors of the partners in
providing mentoring, guidance, and
advice to candidates (including training
in responsible conduct of research and
research integrity, teaching, and
protection of human subjects), and in
fostering the development of academic
and community-based AI/AN
researchers.
B. Review of Research Projects: The
NIH has announced procedures to be
used for the review of research grant
applications (NIH Guide, Volume 26,
Number 22, June 27, 1997, or see https://
grants.nih.gov/grants/guide/notice-files/
not97-010.html and https://
grants.nih.gov/grants/guide/notice-files/
NOT–OD–05–002.html for additional
updated information. For NARCH
applications, the five criteria listed in
this announcement will be used for the
scientific review of research projects
and pilot research projects. The review
of research projects and pilot research
projects will be the same except that
applications for pilot studies may be
smaller in scope and would not be
expected to have preliminary data.
In the written comments, reviewers
will be asked to discuss the following
aspects of the application in order to
judge the likelihood that the proposed
research will have a substantial impact
on the pursuit of these purposes. Each
of these criteria will be addressed and
considered in assigning the overall
score, weighting them as appropriate for
each application.
• Significance: Does this study
address an important problem? If the
aims of the application are achieved,
how will scientific knowledge or
clinical practice be advanced? What will
be the effect of these studies on the
concepts, methods, technologies,
treatments, services, or preventative
interventions that drive this field?
• Approach: Are the conceptual or
clinical framework, design, methods,
and analyses adequately developed,
well integrated, well reasoned, and
appropriate to the aims of the project?
Does the applicant acknowledge
potential problem areas and consider
alternative tactics?
• Innovation: Is the project original
and innovative? For example: Does the
project challenge existing paradigms or
clinical practice; address an innovative
hypothesis or critical barrier to progress
in the field? Does the project develop or
employ novel concepts, approaches,
methodologies, tools, or technologies for
this area?
• Investigators: Are the investigators
appropriately trained and well suited to
VerDate Aug<31>2005
20:35 Jan 23, 2008
Jkt 214001
carry out this work? Is the work
proposed appropriate to the experience
level of the principal investigator and
other researchers? Does the investigative
team bring complementary and
integrated expertise to the project (if
applicable)?
• Environment: Does the scientific
environment in which the work will be
done contribute to the probability of
success? Do the proposed studies
benefit from unique features of the
scientific environment, or subject
populations, or employ useful
collaborative arrangements? Is there
evidence of institutional support?
In addition to the above criteria, in
accordance with NIH policy, all
applications will also be reviewed with
respect to the following:
• The adequacy of plans, if research
on human subjects is involved, to
include both genders and children as
appropriate for the scientific goals of the
research. Plans for the recruitment and
retention of subjects will also be
evaluated.
• The reasonableness of the proposed
budget and duration in relation to the
proposed research.
• The adequacy of the proposed
protection for humans, animals or the
environment, to the extent they may be
adversely affected by the project
proposed in the application.
• The adequacy of the proposed plan
to share data, if appropriate.
VI Award Administration Information
1. Award Notices
The Notice of Award (NoA) will be
initiated by the IHS Division of Grants
Operations (DGO) and will be mailed
via postal mail to each entity that is
approved for funding under this
announcement. The NoA will be signed
by the Grants Management Officer and
this is the authorizing document for
which funds are dispersed to the
approved entities. The NoA will serve
as the official notification of the grant
award and will reflect the amount of
Federal funds awarded, the purpose of
the grant, the terms and conditions of
the award, the effective date of the
award, and the budget/project period.
The NoA is a legally binding document.
Applicants who are approved but
unfunded or disapproved based on their
objective review score will receive a
copy of the Executive Summary which
identifies the weaknesses and strengths
of the application submitted.
2. Administrative and Policy
Requirements
A. Grants are administrated in
accordance with the following
documents:
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
4245
• This Announcement.
• Administrative Requirements: 45
CFR part 92, (Uniform Administrative
Requirements for Grants and
Cooperative Agreements to State, Local
and Tribal Governments), or 45 CFR
part 74, (Uniform Administrative
Requirements for Awards to Institutions
of Higher Education, Hospitals, Other
Non-Profit Organizations, and
Commercial Organizations).
• Grants Policy Guidance: HHS
Grants Policy Statement, January 2007.
• Cost Principles: OMB Circular A–
87, (State, Local, and Indian Title 2 Part
225).
• Cost Principles: OMB Circular A–
122, (Non-profit Organizations Title 2
Part 230).
• Audit Requirements: OMB Circular
A–133, (Audits of States, Local
Governments, and Non-profit
Organizations).
B. Inclusion of Women and Minorities
in Research Involving Human Subjects:
It is the policy of the NIH that women
and members of minority groups and
their subpopulations must be included
in all NIH-supported biomedical,
clinical, behavioral and health services
research projects involving human
subjects; unless a clear and compelling
rationale and justification is provided
that inclusion is inappropriate with
respect to the health of the subjects or
the purpose of the research. This policy
results from the NIH Revitalization Act
of 1993 (Section 492B of Pub. L. 103–
43). Because the NARCH initiative
targets AI/AN people and communities,
a minority population, only the policy
of inclusion of women applies to this
RFA. The IHS has fully accepted the
Office for Human Research Protections
(OHRP) policy regarding human
subjects. The OHRP Web site is https://
www.hhs.gov/ohrp/. All investigators
proposing research involving human
subjects should read the Updated NIH
Guidelines for Inclusion of Women and
Minorities as Subjects in Clinical
Research, published in the NIH Guide
for Grants and Contracts on August 2,
2000.
• (https://grants.nih.gov/grants/guide/
notice-files/NOT-OD-00-048.html). The
complete Guidelines are available at:
https://grants1.nih.gov/grants/funding/
women_min/
guidelines_amended_10_2001.htm. The
revisions relate to NIH defined Phase III
clinical trials and require:
• All applications or proposals and/or
protocols to provide a description of
plans to conduct analyses, as
appropriate, to address differences by
sex/gender and/or racial/ethnic groups,
including subgroups if applicable; and
E:\FR\FM\24JAN1.SGM
24JAN1
jlentini on PROD1PC65 with NOTICES
4246
Federal Register / Vol. 73, No. 16 / Thursday, January 24, 2008 / Notices
• All investigators to report accrual,
and to conduct and report analyses, as
appropriate, by sex/gender and/or
racial/ethnic group differences.
C. Inclusion of Children as
Participants in Research Involving
Human Subjects: It is the policy of NIH
that children (i.e., individuals under the
age of 21) must be included in all
human subjects research, conducted or
supported by the NIH, unless there are
scientific or ethical reasons not to
include them. This policy applies to all
initial (Type 1) applications submitted.
All investigators proposing research
involving human subjects should read
the NIH Policy and Guidelines on the
Inclusion of Children as Participants in
Research Involving Human Subjects that
was published in the NIH Guide for
Grants and Contracts, March 6, 1998,
and is available at the following URL
address: https://grants.nih.gov/grants/
guide/notice-files/not98–024.html.
Investigators may obtain copies of these
policies from the initiative staff listed
under VII. Agency Contacts. Initiative
staff may also provide additional
relevant information concerning the
policy.
D. URLS in NIH Grant Applications or
Appendices: All applications and
proposals for NIH funding must be selfcontained within specified page
limitations. Unless otherwise specified
in an NIH solicitation, Internet
addresses (URLs) should not be used to
provide information necessary to the
review because reviewers are under no
obligation to view the Internet sites.
Reviewers are cautioned that their
anonymity may be compromised when
they directly access an Internet site.
E. Allowable Administrative Costs:
Certain administrative costs for
managing a comprehensive program are
allowable and may vary, depending
upon the size and complexity of the
program’s activities. The costs budgeted
for NARCH grants and subcontracts may
not duplicate items already budgeted in
other cost centers of the AI/AN,
research-intensive, and subcontracted
organizations and institutions, such as
accounts which make up the Facilities
and Administration (F&A) cost pool.
The grantee organization receiving the
award must be prepared to provide
documentation showing the direct
relationship of proposed costs to the
program, and that costs of this type are
charged in a uniform manner to all other
grants at all institutions and
organizations participating in the award.
Limited salary support for secretarial
or clerical help is allowable only when
in direct support of the proposed
NARCH project. For guidance,
applicants should refer to the OMB
VerDate Aug<31>2005
20:35 Jan 23, 2008
Jkt 214001
Circular appropriate for them, A–87
(Cost Principles for State, local, and
Indian Tribal Governments), at https://
www.whitehouse.gov/omb/circulars or
A–122 (Cost Principles for Non-Profit
Organizations), at https://
frwebgate.access.gpo.gov/cgi-bin/
leaving.cgi?from=leavingFR.
html&log=linklog&fxsp0;&to=https://
https://www.whitehouse.gov/omb/
circulars, or should contact the grants
management officer listed under VII.
Agency Contacts.
Costs for evaluation activities are
allowable, as are costs for the
Community and Scientific Advisory
Council. All applications must include
costs associated with one annual
meeting per year in Rockville, MD, of
the project Principal Investigator(s) and
their key scientific personnel.
Applications should also include costs
associated with attendance at the annual
Indian Health Research Conference for
key personnel and trainees.
Student Development Costs: Student
(graduate, undergraduate, and high
school if well justified) remuneration
through salary/wages for participation
in research experiences may be
requested, provided all the following
conditions are met:
I. The student is performing necessary
work involved in the research;
II. There is an employer-employee
relationship between the student and
the proposed NARCH or its partners;
III. The total compensation is
reasonable for the work performed; and
IV. It is the practice of the proposed
NARCH or its partners to provide
compensation for all students in similar
circumstances, regardless of the source
of support for the activity.
Graduate students, but not
undergraduate students, are allowed
tuition costs as part of a compensation
package. When requesting support for a
graduate student, the NARCH
application should provide, in the
budget justification section of the
application, the basis for the
compensation level. The IHS staff will
review the requested compensation
level and, if it is reasonable and
justified, will provide compensation up
to a maximum of $45,000 (https://
grants.nih.gov/grants/guide/notice-files/
not98–168.html). Post-doctoral students
should be compensated at a rate
commensurate with that of other postdoctoral employees with similar degrees
and experience at the research-intensive
institution. It is the expectation of the
IHS and NIGMS that students who are
enrolled in a accredited graduate
program, as part of a proposed NARCH,
will not be excluded from support from
other non-Federal or Federal graduate
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
training sources (such as loans and
assistance under the Veterans’
Adjustment Benefit Act or Pell Grants)
for which they are eligible.
Graduate and post-doctoral students
cannot concurrently hold other
Federally-sponsored stipends or
fellowship or any other Federal award
that duplicates the NARCH support.
Faculty/Researcher Development
Costs:
Faculty/Researcher Development
Costs: Costs to support faculty/
researcher development activities, such
as workshops or courses, national
meetings, or short-term research
experiences in the laboratory of an
active NIH-extramurally-funded
researcher needed for acquiring specific
skills or methodologies needed for
prospective research, are allowable.
Such costs might include tuition, travel
and per diem costs, as well as salary
support appropriate to the percent effort
needed for the activity.
Research Project Costs: Direct costs
associated with research and pilot
research projects are allowable when
adequate justification is provided. These
include faculty/researcher salaries,
reimbursed according to percent effort.
Summer salary support can be paid
provided the institution’s academic
schedule permits such release and when
the institution approves. The maximum
summer-salary support provided by the
program cannot exceed the equivalent of
three months at 100 percent effort, or
time specified by the institution as its
policy. Grant funds may not be used to
increase or supplement faculty/
researcher academic year salaries.
Salary support for technical assistance
and costs for consultants, if justified, are
allowable. Costs for equipment to be
used to carry out the proposed research
are allowable.
Cost for Supplies: Costs for supplies,
including costs for animals necessary to
carry out the proposed research, may be
included. Travel costs for the
investigator(s) are permitted when
direct benefits to the program are
expected, and when adequate
justification is provided. Alterations and
renovations costs (up to $40,000) are
allowable only when essential for
conduct of the proposed research. Other
permitted costs include animal
maintenance (unit care costs and
number of care days), donor fees,
publication costs, computer charges,
rentals and leases, equipment
maintenance, and service contracts.
Consortium and Contract
Arrangements: Consortium
arrangements that may involve
personnel costs, supplies, and other
allowable costs, including F&A costs;
E:\FR\FM\24JAN1.SGM
24JAN1
jlentini on PROD1PC65 with NOTICES
Federal Register / Vol. 73, No. 16 / Thursday, January 24, 2008 / Notices
contractual costs for support services,
such as the laboratory testing of
biological materials, clinical services,
data processing, or core administrative
services, are allowable expenses.
Consortia and contractual costs with
Native health organizations, Tribes and/
or research institutions in Canada or
Mexico are allowable expenses.
Pilot Research Projects: The intent of
pilot research projects is to lead to
regular research projects funded as part
of the center grant or as freestanding
grants. For pilot research projects,
applications may request support for up
to $50,000 (direct costs) per year for up
to four years. This pilot research
support is non-renewable. However,
NARCH research projects based on prior
NARCH pilot research projects are
encouraged.
Subcontracts: The grant recipient may
issue subcontracts to other organizations
(such as the research-intensive
institution of the partnership), as long as
a minimum of 30 percent of the grant
funds are budgeted in the application to
remain with the eligible AI/AN
organization(s); that is, no more than 70
percent of the application’s total budget
may be contained in subcontract
budgets of the non-eligible
subcontracting partner institutions or
organizations.
F. Unallowable Costs: Unallowable
costs for research projects (including for
pilot projects) include costs for student
development, textbooks, journals,
memberships, and Internet subscription
costs, as well as other costs prohibited
by OMB Circulars A–87 or A–122 as
applicable. Employees of the applicant
organization may not serve as paid
consultants but may be paid. The pilot
research project is intended for faculty/
researcher without current Federal
research support. Therefore,
investigators with significant current.
support from other mechanisms such as
the RO1 and research funding from
other extramural sources are not
eligible, and the costs therefore are not
allowable. Release time for preparing
proposals or mini-research projects, not
submitted as pilot projects, is not
allowed.
G. Research Subjects Protection:
Under governing policy, Federal funds
administered by the HHS shall not be
expended for research involving live
vertebrate animals without prior
approval by the NIH Office of
Laboratory Animal Welfare (OLAW), of
an assurance to comply with the Public
Health Service (PHS) Policy on Humane
Care and Use of Laboratory Animals.
This restriction applies to all
performance sites (e.g., collaborating
institutions, subcontractors,
VerDate Aug<31>2005
20:35 Jan 23, 2008
Jkt 214001
subgrantees) without OLAW-approved
assurances, whether domestic or
foreign. Funds included in this award
may not be used to support studies
using live vertebrate animals until
approval from the Institutional Animal
Care and Use Committee (IACUC) has
been received by the IHS Grants
Management Officer (GMO).
Federal Regulations (45 CFR, Pt. 46)
require that applications and proposals
involving human subjects must be
evaluated with reference to the risks to
the subjects, the adequacy of protection
against these risks, the potential benefits
of the research to the subjects and
others, and the importance of the
knowledge gained or to be gained.
Under governing regulations 45 CFR
Part 46, found at https://www.hhs.gov/
ohrp/humansubjects/guidance/
45cfr46.htm. Federal funds
administered by HHS shall not be
expended for research involving human
subjects, and individuals shall not be
enrolled in such research, without prior
approval by the Office for Human
Research Protections (OHRP), of an
appropriate Federal Wide Assurance
(FWA) and prior approval by an
Institutional Review Board (IRB)
recognized and listed by the OHRP.
Funds included in this award may not
be used to support studies using human
subjects until evidence of IRB approval
has been received by the IHS GMO.
Applicants are expected to provide their
own institutional FWA.
H. Research Integrity—Grantees shall
comply with Public Health Service
Policies on Research Misconduct (42
CFR Part 93) which require grantees to
have procedures for responding to
allegations of research misconduct that
comply with those policies, to submit
their procedures to the Office of
Research Integrity (ORI) (https://
ori.hhs.gov) upon request for review,
and revise their procedures in
accordance with ORI comments. In
addition, grantees shall file the Annual
Report on Possible Research Misconduct
with ORI at https://www.ori.dhhs.gov/
assurance/electronic_submission.shtml.
Grantees shall file documentation of
their Annual Reports with the IHS
GMO.
1. Healthy People 2010: The Public
Health Service (PHS) is committed to
achieving the health promotion and
disease prevention objectives of Healthy
People 2010, a PHS led national activity
for setting priority areas. This RFA
announcement is related to one or more
of the priority areas. Potential
applicants may obtain a copy of Healthy
People 2010 at: https://
www.healthypeople.gov.
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
4247
3. Indirect Costs: This section applies
to all grant recipients that request
reimbursement of indirect costs in their
grant application, but not to the indirect
costs that may be negotiated by the
grantees with their subcontractors
(which become direct costs to the
grantee). In accordance with HHS
Grants Policy Statement, Part II–27, IHS
requires applicants to have a current
indirect cost rate agreement in place
prior to award. The rate agreement must
be prepared in accordance with the
applicable cost principles and guidance
as provided by the cognizant agency or
office. A current rate means the rate
covering the applicable activities and
the award budget period. If the current
rate is not on file with the DGO at the
time of award, the indirect cost portion
of the budget will be restricted and not
available to the recipient until the
current rate is provided to DGO.
Generally, indirect costs rates for IHS
grantees are negotiated with the
Division of Cost Allocation (DCA)
https://rates.psc.gov/ and the Department
of Interior (National Business Center)
https://www.nbc.gov/acquisition/ics/
icshome.html. If your organization has
questions regarding the indirect cost
policy, please contact the DGO at (301)
443–5204.
4. Reporting
A. Progress Report. Program progress
reports are required semi annually.
These reports will include a brief
comparison of actual accomplishments
to the goals established for the period,
or, if applicable, provide sound
justification for the lack of progress, and
other pertinent information as required.
A final progress report, cumulative from
the beginning of the project period,
must be submitted within 90 days of
expiration of each budget period.
B. Financial Status Report. Quarterly
financial status reports must be
submitted within 30 days of the end of
each quarter. Final financial status
reports are due within 90 days of
expiration of the budget/project period.
Standard Form 269 (long form) will be
used for financial reporting.
C. Reports. Grantees are responsible
and accountable for accurate reporting
of the Progress Reports and Financial
Status Reports. Financial Status Reports
(SF–269) are due 90 days after each
budget period and the final SF–269
must be verified from the grantee
records on how the value was derived.
Grantees must submit reports in a
reasonable period of time.
Failure to submit required reports
within the time allowed may result in
suspension or termination of an active
grant, withholding of additional awards
for the project, or other enforcement
E:\FR\FM\24JAN1.SGM
24JAN1
4248
Federal Register / Vol. 73, No. 16 / Thursday, January 24, 2008 / Notices
actions such as withholding of
payments or converting to the
reimbursement method of payment.
Continued failure to submit required
reports may result in one or both of the
following: (1) The imposition of special
award provisions; and (2) the nonfunding or non-award of other eligible
projects or activities. This applies
whether the delinquency is attributable
to the failure of the grantee organization
or the individual responsible for
preparation of the reports.
5. Telecommunication for the hearing
impaired is available at: TTY (301) 443–
6394.
Agency Contact(s)
1. Questions on the initiative,
regarding IHS NARCH issues and
policies, may be directed to: Alan
Trachtenberg, MD, MPH, Division of
Planning, Evaluation and Research,
Indian Health Service, 801 Thompson
Avenue, TMP Suite 450, Rockville, MD
20852, Telephone: (301) 443–4700, Fax:
(301) 443–0114, e-mail: narch@ihs.gov.
2. Questions on grants management
and fiscal matters may be directed to:
Sylvia Ryan, Division of Grants
Operations, Indian Health Service,
Reyes Building, 801 Thompson Avenue,
TMP Suite 350, Rockville, MD 20852,
Telephone: (301) 443–5204, Fax: (301)
443–9602, e-mail: narch@ihs.gov.
3. Questions on NIGMS issues and
policies, may be directed to: Clifton A.
Poodry, Ph.D., Minority Opportunities
in Research Division, National Institute
of General Medical Sciences, 45 Center
Drive, Suite 2AS.37, MSC 6200,
Bethesda, MD 20892, Telephone: (301)
594–3900, Fax: (301) 480–2753, e-mail:
poodryc@nigms.nih.gov.
4. Questions on the review of
applications may be directed to:
Mushtaq A. Khan, D.V.M., Ph.D., Chief,
Digestive and Respiratory Sciences
IRGs, Center for Scientific Review, MSC
7818, Room 2176; 6701 Rockledge
Drive; Bethesda, MD 20892 (20817 for
courier or express service) Telephone:
(301) 435–1778; Fax: (301) 451–2043; email: khanm@csr,nih.gov.
jlentini on PROD1PC65 with NOTICES
Other required documents
If the applicant is a Federallyrecognized Tribe, Tribal organization, or
a Tribal college letters of support from
the Chairman, President, Governor or
Tribal Health Director is required of all
Tribes to be served to show their
support of the grant project. Letters of
support are intended to document that
applicants have Tribal support for the
specific grant for which they are
applying. All letters of support must
accompany the grant application.
VerDate Aug<31>2005
20:35 Jan 23, 2008
Jkt 214001
Other Information
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
References for Background
Information:
Anderson, N.B. Levels of analysis in health
science: A framework for integrating
sociobehavioral and biomedical research.
Annals of the New York Academy of
Sciences, 1998, 840, 563–576.
Ballantine, B., Ballantine, I. (Eds.),
Thomas, D.H., Miller, J., White, R., Nabokov,
P., Deloria, P.J. (Text by), Joseph, A.M.
(Intro.) The Native Americans: An Illustrated
History. Turner Publishing, Inc. Atlanta, GA,
1993.
Freeman, W.L. The role of community in
research with stored tissue samples. Weir R
(Ed.) Stored tissue samples: Ethical, legal,
and public policy implications. University
Iowa Press. Iowa City, lA, 1998, 267–301.
Gazmararian, J.A., Baker, D.W., Williams,
M.V., Parker, R.M., Scott, T.L., Green, D.C.,
Fehrenbach, S.N., Ren, J. & Koplan, J.P.
Health literacy among Medicare enrollees in
a managed care organization. Journal of the
American Medical Association, 1999, 281,
545–551.
Haynes, M.A. & Smedley, B.D. (Eds.) The
Unequal Burden of Cancer: An Assessment of
NIH Programs for Ethnic Minorities and the
Medically Underserved. Institute of
Medicine. National Academy Press.
Washington, DC, 1999.
Macaulay, A.C., Commanda, L.E., Freeman,
W.L., Gibson, N., McCabe, M.L., Robbins,
C.M., & Twohig, P.L., (for the) North
American Primary Care Research Group.
Participatory research maximizes community
and lay involvement. British Medical Journal,
1999, 319, 774–778.
Minority Economic Profiles. U.S. Bureau of
the Census, Population Division. Issued July
24, 1992. (Tables 1990 CPH–L–92, 93, 94 and
95).
NIH Publication 98–4247. Women of Color
Health Data Book. Office of Research On
Women’s Health, Office of the Director,
National Institutes of Health, 1998.
Trends in Indian Health 1998–99. Program
Statistics Team, Office of Public Health,
Indian Health Service, 2001.
Regional Differences in Indian Health
1998–99. Program Statistics Team, Office of
Public Health, Indian Health Service, 2000.
Weiss, B.D., Reed, R.L., & Kligman, E.W.
Literary skills and communication methods
of low-income older persons. Patient
Education and Counseling, 1995, 25, 109–
119.
Williams, D.R. & Collins, C. U.S.
Socioeconomic and Racial Differences in
Health: Patterns and Explanations. Annual
Review of Sociology, 1995, 21, 349–386.
Williams, M.V., Parker, R.M., Baker, D.W.,
Parikh, N.S., Pitkin, K., Coates, W.C., &
Nurss, J.R. Inadequate functional health
literacy among patients at two public
hospitals. Journal of the American Medical
Association, 1995, 274, 1677–1682.
Dated: January 16, 2008.
Robert G. McSwain,
Acting Director, Indian Health Service.
[FR Doc. 08–243 Filed 01–23–08; 8:45 am]
BILLING CODE 4165–16–M
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
Office of Inspector General
Solicitation of Information and
Recommendations for Revising the
Compliance Program Guidance for
Nursing Facilities
Office of Inspector General
(OIG), HHS.
ACTION: Notice.
AGENCY:
This Federal Register notice
seeks the input and recommendations of
interested parties as OIG revises the
compliance program guidance (CPG) for
nursing facilities, especially those
serving Medicare, Medicaid, and other
Federal health care program
beneficiaries. The nursing home
industry has experienced a number of
changes since OIG first published a CPG
in this area (65 FR 14289; March 16,
2000). Additionally, the subsequent
years of enforcement and compliance
activity in the nursing home industry
has allowed OIG to address more fully
the various risk areas in nursing home
compliance. In evaluating the contents
of the nursing facility CPG, OIG is
soliciting comments, recommendations,
and other suggestions from concerned
parties and organizations on how best to
revise the nursing facility CPG to
address relevant compliance issues.
Specifically, OIG seeks comments
addressing any changes to existing risk
areas and introducing any new risk
areas.
SUMMARY:
To assure consideration,
comments must be delivered to the
address provided below by no later than
5 p.m. on February 25, 2008.
ADDRESSES: In commenting, please refer
to file code OIG–126–N. Because of staff
and resource limitations, we cannot
accept comments by facsimile (FAX)
transmission.
You may submit comments in one of
three ways (no duplicates, please):
1. Electronically. You may submit
electronic comments on specific
recommendations and suggestions
through the Federal eRulemaking Portal
at https://www.regulations.gov.
(Attachments should be in Microsoft
Word, if possible.)
2. By regular, express, or overnight
mail. You may send written comments
to the following address: Office of
Inspector General, Department of Health
and Human Services, Attention: OIG–
126–N, Room 5246, Cohen Building,
330 Independence Avenue, SW.,
Washington, DC 20201. Please allow
sufficient time for mailed comments to
DATES:
E:\FR\FM\24JAN1.SGM
24JAN1
Agencies
[Federal Register Volume 73, Number 16 (Thursday, January 24, 2008)]
[Notices]
[Pages 4235-4248]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 08-243]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Indian Health Service
Native American Research Centers for Health (NARCH) Grants
Announcement Type: New and Competing Continuations.
Funding Announcement Number: HHS-2009-IHS-NARCHV-0001.
Catalog of Federal Domestic Assistance Number(s): 93.933.
Key Dates: Letter of Intent Deadline: March 15, 2008.
Application Deadline Date: May 16, 2008.
Review Date: October, 2008.
Earliest Anticipated Start Date: June 1, 2009.
I. Funding Opportunity Description
The Indian Health Service (IHS), in conjunction with the National
Institute of General Medical Sciences (NIGMS) and other institutes of
the National Institutes of Health (NIH) announces competitive grant
applications for Native American Research Centers for Health (NARCH),
an initiative to support new and/or continuing centers or projects
funded under the NARCH grant program. This funding mechanism will
develop further opportunities for conducting research and research
training to meet the needs of American Indian/Alaska Native (AI/AN)
communities. This program is authorized under the Snyder Act, 25 U.S.C.
13, the Public Health Service Act, 42 U.S.C. 241 as amended, and the
Indian Health Care Improvement Act, 25 U.S.C. 1602(a)(b)(16). This
program is described at 93.933 in the Catalog of Federal Domestic
Assistance.
Background Information: TheAI/AN Tribal nations and communities
have long experienced health status worse than that of other Americans.
Although major gains in reducing health disparities were made during
the last half of the twentieth century, most gains stopped by the mid-
1980s (Trends in Indian Health 1998-99) and a few diseases, e.g.,
diabetes, worsened. ``All Indian'' rates contain marked variation among
the IHS Areas or regions (Regional Differences in Indian Health 1998-
99); and variation by Tribe exists within Areas as well. The Trends and
Regional Differences reference can be found at the IHS Web site at:
https://www.ihs.gov/NonMedicalPrograms/IHS_Stats. Although the AI/AN
mortality rates for all cancers are about 20 percent lower than the
U.S. rates for all races, there is variation among IHS Areas for
specific cancers. Moreover, the favorable AI/AN mortality rates for
some cancers may be due to markedly lower incidence rates partly offset
by higher case-fatality rates. Unfamiliarity with modern health care
may adversely influence health status among the elderly, the low-income
elderly, and Tribes, and also may reduce the acceptability of health
research among them. The daunting tasks confronting Tribes,
researchers, and health care and public health programs in the
beginning of the twenty-first century are to resume the reduction of
health disparities that had occurred through the 1980s, to reverse the
worsening in a few diseases, to maintain and strengthen the favorable
status, and to reduce the disparities among and within Areas and
Tribes. Factors known to contribute to health status and disparities
are complex, and include underlying biology, physiology, and genetics,
as well as ethnicity, culture, socioeconomic status, gender/sex, age,
geographical access to care, and levels of insurance. Additional
factors known to contribute to health status and dispariteis include:
1. Family, home, and work environments;
2. General or culturally specific health practices;
3. Social support systems;
4. Lack of access to culturally-appropriate health care; and
5. Attitudes toward health.
Yet none of these along or in combination accounts for all
documented differences. Health disparities of AI/ANs may also reflect a
lack of in-depth research relevant to improving their health status.
Many AI/ANs distrust research for historical reasons. One approach that
combats this distrust is to ensure that Tribes are the managing
partners in training and research that involves them, as for example,
in community-based participatory research (CBPR) (i.e., a collaborative
research process between researchers and community representatives).
This approach is especially helpful to design both training relevant to
researchers from Tribal communities, and research relevant to the
health needs of the communities.
Research Objectives: The NARCH initiative will support partnerships
between Federally Recognized AI/AN Tribes Organizations (including
national and area Indian Health Boards, and Tribal colleges meeting the
definition of a Tribal organization as defined by 25 U.S.C. 1603(e))
and institutions that conduct intensive academic-level biomedical,
behavioral and health services research. These partnerships are called
Native American Research Centers for Health (NARCH). Due to the
complexity of factors contributing to the health and disease of AI/ANs,
and to their health disparities compared with other Americans, the
collaborative efforts of the agencies of the Department of Health and
Human Services (HHS) and the collaboration of researchers and AI/AN
communities are needed to achieve significant improvements in the
health status of AI/AN people. To accomplish this goal, in addition to
objectives set by the Tribe, Tribal Organization or Indian Health
Boards, the IHS NARCH program will pursue the following program
objectives:
To develop a cadre of AI/AN scientists and Health
Professionals--Opportunities are needed to develop more AI/AN
scientists and health professionals engaged in research, and to conduct
biomedical, clinical, behavioral and health services research that is
responsive to the needs of the AI/AN community and the goals of this
initiative. Faculty/researchers and students at each proposed NARCH
will develop investigator-initiated, scientifically meritorious
research projects, including pilot research projects, and will be
supported through science education projects designed to increase the
numbers of, and to improve the research skills of, AI/AN investigators
and investigators involved with AI/ANs.
To enhance Partnerships and reduce distrust of research by
AI/AN communities--Recent community-based participatory research
suggests that AI/AN communities can work collaboratively in partnership
with health researchers to further the research needs of AI/ANs. Fully
utilizing all cultural and scientific knowledge, strengths, and
competencies, such partnerships can lead to better understanding of the
biological, genetic, behavioral, psychological, cultural, social, and
economic factors either promoting or hindering improved health status
of AI/ANs, and generate the development and evaluation of interventions
to improve their health status. Community distrust of research and
researchers will be reduced by offering the Tribe greater control over
the research process.
To Reduce Health Disparities--In the Indian Health Care
Improvement Act, Pub. L. 94-437 (as amended), IHS was legislatively
mandated to improve
[[Page 4236]]
the delivery of effective health care to AI/ANs. In the NIH
Revitalization Act of 1993, NIH was encouraged to increase the number
of under-represented minorities participating in biomedical, clinical,
and behavioral research, including studies on drug abuse and
alcoholism, and the examination of the role of resiliency in the
prevention and treatment of those conditions. Also, the ``Initiative to
Eliminate Racial and Ethnic Disparities in Health'' by HHS (https://
www.omhrc.gov/rah) encouraged NIH to help reduce health disparities. In
response to these priorities, the IHS and NIH have established a
collaboration to support the NARCH.
Reducing health disparities among AI/AN communities and individuals
may be fostered by greater understanding of how to enhance their
strengths and resilience. While AI/AN communities have relied on health
research and medical science to reduce health disparities, they have
also relied on their own psychological, organizational, and cultural
assets and strengths to survive major harms and disruptions over the
centuries, and to rebound from insults to health.
The mission of NIH is to acquire new knowledge that will lead to
better health by understanding the processes underlying health and
disease that in turn will help prevent, detect, diagnose, and treat
disease and disability. The NARCH initiative works toward the NIH
mission by supporting research that discovers the interrelationships
among the many factors that contribute to health and disease, and by
helping to train and promote AI/AN researchers and researchers
concerned with AI/AN health.
II. Award Information
Type of Awards: Grant.
Estimated Funds Available: The estimated funds (total costs)
available for the first year of support for the entire initiative is
expected to be at least $3.0 million in Fiscal Year 2009. The actual
amount may vary, depending on the response to the request for
applications (RFA) and availability of funds. An applicant may request
a project period not to exceed four years of support, and direct costs
not to exceed $1,000,000 per center or $500,000 per project (research
or training) in the first year of each award. Direct costs to the
applicant include the total cost of each subcontract (subcontractor
direct plus subcontractor indirect costs).
Anticipated Number of Awards: An estimated five to fifteen awards
will be made under the program.
Award Amount: $100,000-$1,000,000 per year.
III. Eligibility Information
The new or existing NARCH must be a working partnership of the
eligible AI/AN organization and of the research-intensive institution.
Applicants eligible to receive the NARCH award are Federally recognized
Tribes and Tribal organizations as defined under the Indian Health Care
Improvement Act, 25 U.S.C. 1603(d) and (3), including eligible Indian
Health Boards or Tribal Colleges applying on behalf of eligible
Federally recognized Tribes or Tribal organizations. As the grantee,
the eligible AI/AN organization will define criteria and eligibility
for participation in all aspects of the partnership, consistent with
this announcement. A minimum of 30 percent of the grant funds must be
budgeted in the application to remain with the eligible AI/AN
organization(s); that is, no more than 70 percent of the application's
total budget may be contained in subcontract budgets of the non-
eligible subcontracting partner institutions or organization.
1. Eligible Applicants--The AI/AN applicant must be one of the
following:
A federally-recognized AI/AN Tribe, as defined under 25
U.S.C. 1603(d); or
A Tribal organization, as defined under 25 USC 1603(e),
including Tribal Colleges or health boards meeting this definition; or
A consortium of two or more of those Tribes or Tribal
organizations.
Applicants other than Tribes must provide proof of non-profit
status.
2. Cost Sharing or Matching--The NARCH program does not require
matching funds or cost sharing.
3. The Research-Intensive Partner: The Research-Intensive Partner
must be an accredited public or private nonprofit university or other
institution that has an established record of conducting research into
the health problems of AI/AN; has demonstrated a commitment to
enhancing the capability of AI/AN faculty/researchers, students,
investigators, and communities to engage in biomedical, behavioral,
clinical and health services research; and has demonstrated a
commitment to mentoring AI/AN faculty/researchers, students, and
investigators.
4. Principal Investigator: The Principal Investigator, the
individual responsible for the administration (including fiscal
management) of the overall project, must have his/her primary
appointment with the AI/AN applicant organization. Special arrangements
of employment, such as inter-organizational personnel agreements, are
permissible. The Principal Investigator may be, but is not required to
be, the NARCH Program Director or a Research Project Investigator. The
NARCH Principal Investigator may or may not have formal academic/
research credentials, but if not, then the NARCH Program Director must
be so qualified.
The traditional NIH research project grant consists of a single
Principal Investigator (PI) working with a small group of subordinates
on an independent research project. Although this model clearly
continues to work well and encourages creativity and productivity, it
does not always work well for multidisciplinary efforts and
collaboration. Increasingly, health-related research involves teams
that vary in terms of size, hierarchy, location of participants, goals,
disciplines, and structure. There is growing consensus that team
science would be encouraged if more than one PI could be recognized on
individual awards. The NIH has adopted a multiple-PI model, as recently
directed by the Office of Science and Technology Policy. All agencies
that have research and research-related programs must offer the
multiple-PI model as an option. Note, it is only an option, not a
requirement. The traditional NARCH division of roles between Principal
Investigator and Project Director will usually address these issues to
a satisfactory degree. For additional information regarding the new
multiple-PI model, please click on the following Web site: https://
grants.nih.gov/grants/multi_pi/index.htm.
5. NARCH Program Director: The NARCH Program Director is the
individual responsible for the day-to-day leadersip and management of
the research and training programs within the proposed NARCH. The
Program Director may be, but is not required to be, the Student and
Faculty/Researcher Development Director or a Research Project
Investigator. The NARCH Program Director may or may not have formal
academic/research credentials, but if not, then the Principal
Investigator must be so qualified.
6. Student and Faculty/Researcher Development Director and
Participants: The NARCH initiative is an institutional developmental
grant mechanism that places an emphasis on the continual development of
students and faculty/researchers. If a new Student and/or Faculty/
Researcher Development Program is proposed in the current application,
then the Principal Investigator of that project is expected to be the
NARCH Student and Faculty Development Director. In order to be included
as the Student and Faculty
[[Page 4237]]
Development Director, the prospective director must have a faculty/
researcher appointment at the research-intensive institution (or
equivalent appointment at the AI/AN organization or other consortium
partner) and must demonstrate that he/she has the knowledge, skills,
and capabilities to mentor students and faculty/researchers and to
generate and direct development and mentoring programs.
The Student and Faculty Development Director may be the NARCH
Program Director. Faculty/researchers and students should be supported
in research education activities that improve their skills and
abilities to be successful at the next stage of their professional
development. To be included as a participant for faculty/researcher
development in the proposed NARCH, the individual must have a faculty/
researcher appointment at the research-intensive institution or
equivalent appointment at the AI/AN organization or consortium partner.
7. Research Project Investigators: The NARCH initiative is an
institutional developmental grant mechanism that places an emphasis on
continual improvement of the research competitiveness of the research
investigators. In order to be included as a research project
investigator in the NARCH, a prospective investigator must have a
faculty appointment at the research-intensive institution or equivalent
appointment at the AI/AN organization or other consortium partner, and
must show that he/she has the need, based on institutional,
departmental, and professional development plans, to enhance his/her
research knowledge, skills, and capabilities by engaging in the
proposed research program and associated activities.
8. Tribal Approval of the Application: It is the policy of the IHS
that all research involving AI/AN Tribes be approved by the Tribal
governments with jurisdiction. Therefore, the following documentation
is required as part of the application for new or continuing centers or
additional NARCH projects:
Tribal Resolution: If the applicant is an Indian Tribe or
Tribal organization, a resolution from the Tribal government of all
Tribes to be served supporting the project must accompany the
application submission. Applications by Tribal organizations will not
require resolutions if the current Tribal resolutions under which they
operate would encompass the proposed activities. In this instance a
copy of the current resolution must accompany the application. The
listed Tribes to be served by the project in the proposal must match
the set of appended resolutions. If a resolution from an appropriate
representative of each Tribe to be served is not submitted prior to
November 1, 2008, the application will be considered incomplete and
will not be considered for funding.
An official signed resolution must be received by November 1, 2008
to the Division of Grants Operation by (DGO), IHS, at the Reyes
Building, 801 Thompson Avenue, TMP 360, Rockville, MD 20852. A grant
will not be awarded unless the signed resolution is received. Please
include the funding opportunity number, as a reference to this
announcement, if the resolutions are submitted as a separate mailing.
9. Mechanism of Support: Awards under this initiative will be
administered using the competing institutional grant mechanism of the
IHS, and will be reviewed using the NIH S06 mechanism.
IV. Application and Submission Information
1. Address To Request Application Package: NARCH Program Official,
Reyes Building, 801 Thompson Avenue, Rockville, MD 20852 or by e-mail
to narch@ihs.gov. Applicants are strongly encouraged to establish
eligibility of their proposed applications prior to submission.
Inquiries about eligibility should be addressed to Alan Trachtenberg,
MD, MPH, at (301) 443-0578 or by E-mail to narch@ihs.gov. The
application package, including supplemental instructions will be posted
on the IHS Research Program Web site, at: https://www.ihs.gov/
MedicalPrograms/Research/narch.cfm.
The NIH PHS 398 application instructions are available in an
interactive format at: https://grants.nih.gov/grants/funding/phs398/
phs398.html. Applicants must use the currently approved version of the
PHS 398. For further assistance contact GrantsInfo, Telephone (301)
435-0714, E-mail: GrantsInfo@nih.gov, Telecommunications for the
hearing impaired: TTY 301-451-0088.
Submit a typed and signed original application, including the
Checklist, and one (1) single-sided photocopy of the entire application
(including Appendices and supporting documents) in one package to:
Division of Grants Operations, Indian Health Service, Reyes Building,
801 Thompson Avenue, TMP 360, Rockville, MD 20852-1627 (zip code is
unchanged for express/courier services), Telephone: (301) 443-5204.
At the time of submission, applicants must also send four (4)
additional single-sided photocopied and signed applications, including
the Checklist, Appendices, and supporting documentation to: Center for
Scientific Review (CSR), National Institutes of Health, 6701 Rockledge
Drive, Room 6160--MSC 7892, Bethesda, MD 20892-7720, Bethesda, MD 20817
(for express or courier service). Telephone: (301) 435-0715. The CSR no
longer accepts hand delivered applications.
The RFA label available at https://grants1.nih.gov/grants/funding/
phs398/label-bk.pdf in the PDF format, must be affixed to the bottom-
face page of the application. Type this RFA number: ``NOT GM-08-115''
on the label. Failure to use this label could delay processing the
application and it may not reach the review committee in time for
review. In addition, the ``Native American Research Centers for
Health'' and the RFA number must be typed on line 2 of the face page of
the application form and the YES box must be marked. E-mail or other
electronic applications will not be accepted under this announcement.
Specific supplementary instructions for the PHS 398 application and
budget preparation for the NARCH program may be obtained from the
initiative contacts listed under VII. Agency Contacts, and will be
posted at: https://www.ihs.gov/MedicalPrograms/Research/narch.cfm. There
will be no acknowledgment of receipt of the application.
2. Content and Form of Application Submission: A proposed NARCH may
include any or all of the following components: student development
projects; faculty/researcher development projects; research projects
(including pilot projects); and ``core'' administrative facilities.
The content of the application should explain the components of the
application, and how they help meet the purpose of the NARCH
initiative. A description should be provided of the current state of
the research and research training enterprise at the proposed NARCH and
its institutional and community partners, including faculty/researcher
and student profiles.
A clear statement should be presented of the overall goals,
specific measurable objectives, and anticipated milestones. These
elements should be presented in the context of needed improvements in
the partners' organizational infrastructure and environment for
research. Documentation should be provided to establish that the
research-intensive partner is an institution with a record of
conducting research into the health of AI/ANs, and that it has a
demonstrated commitment to the
[[Page 4238]]
special encouragement of, and assistance to, AI/AN faculty/researchers,
students, investigators, and communities for enhancing their capacity
to engage in biomedical, behavioral and health services research.
Documentation about the nature of the partnership itself should be
included, such as: the process to develop the application and proposed
NARCH itself, the past and future efforts to increase the capacity of
the partners to improve their partnership, and efforts to contribute to
the success of the NARCH.
A plan for assessment of the benefits of the activities by the
proposed NARCH on specific, measurable outcomes identified in the
application should be provided. IHS and NIGMS recognize that Tribes,
Tribally-based organizations, and research-intensive institutions are
diverse in their missions, their health and economic status, and their
cultures. Such an assessment could include a self-study by the proposed
NARCH and its partners, which focuses on fact-finding, program
evaluation, and recommendations for improvement in key areas.
Strategies for determining the initial and ongoing success of their
efforts for organizational development should also be presented. It is
expected that each proposed NARCH will develop its own set of
strategies that best match its circumstances. Guidance and suggestions
for program evaluation of a proposed NARCH can be obtained from https://
www.the-aps.org/education/promote/promote.html.
Applications are strongly urged to contact NARCH initiative staff
at an early stage to request the specific supplementary instructions
for the PHS 398 for the NARCH grants. Supplementary instructions may be
obtained from the initiative contacts listed under VII. Agency
Contacts, and will be posted at: https://www.ihs.gov/MedicalPrograms/
Research/narch.cfm.
If Student Development Projects are proposed, the NARCH application
should describe new programs of modifications or additions to existing
programs of the partners that encourage and facilitate AI/AN students
to enter, advance, and remain in research careers. Such projects might
include, but are not limited to, providing employment as research
assistants in research projects of research-active mentors with an
explicit mentoring plan, providing other mentoring with an explicit
mentoring plan, providing workshops to improve technical or
communication skills, providing motivating seminars or journal clubs
highlighting problems of interest to students, providing contact with
role models, and providing opportunities to travel to present results
at national scientific meetings. If research mentorships or
apprenticeships are proposed, the application should clearly document
the experience, proposed commitment, and quality of the mentors in
providing guidance and advice to students (including responsible
conduct of research and research integrity, teaching, and protection of
human subjects), and in fostering the development of academic and/or
community based AI/AN researchers.
The application should describe how the development plans for the
student will meet both the individual's professional development goals,
and one purpose for the NARCH initiative: to develop a cadre of AI/AN
scientists and health professionals. The application must have an
evaluation plan for the project(s) that indicates the anticipated
outcomes relative to the current baseline data. For example, one
outcome might be the improved retention of AI/AN students in science
majors. The application should indicate the anticipated (quantitative)
improvement relative to the current retention rate.
A student in a NARCH Student Development Project must be a full-
time or part-time student officially enrolled in an educational program
leading to an undergraduate or graduate degree, or in a post-doctoral
educational program, or (if well justified) in a late high school. A
helpful book about mentoring science students is found at https://
book.nap.edu/catalog/5789.html.
If Faculty/Researcher Development Projected are proposed, the NARCH
application should describe the need, proposed activity, and
anticipated outcomes. Faculty/researcher development projects might
include, but are not limited to, short-term mentored research
experiences in the lab of an active NIH-extramurally-funded researcher
with an explicit mentoring plan, long-term general mentoring under an
explicit mentoring plan, or attendance at workshops or courses or
national meetings needed for acquiring specific skills or methodologies
needed for prospective research. As with student development projects,
the application should document the experience, proposed commitment,
and quality of the mentors, teachers, or experience in providing
guidance and advice to faculty/researchers, and in fostering the
development of academic and community-based AI/AN research. The
application must also describe the evaluation plan for the faculty/
researcher development project. The application must clearly describe
how the development plans for faculty/researchers will meet both the
individual's professional development goals, and two purposes of the
NARCH initiative:
To develop a cadre of AI/AN scientists and health
professionals, and
To enhance the partnership of the proposed NARCH.
NARCH applications may include a maximum of five (5) regular
Research Projects and a maximum of five (5) Pilot Research Projects.
Unlike regular research projects, a pilot research project is limited
in scope and is not expected to have preliminary data. It is also
limited to a budget of no more then $50,000 direct costs per year for
four years. The pilot research project is intended for faculty/
researchers without current federal research support. Support for
faculty/researchers participating in pilot research projects is
preparatory to seeking more substantial funding from NIH research grant
programs (e.g., Academic Research Enhancement Award, K and R01 awards),
as well as funding from other agencies and private sources. Funds
received from the proposed NARCH to support pilot research projects may
not be used to supplement ongoing research projects. A NARCH
application need not include both research projects and pilot research
projects. Applications for only pilot research projects or for only
research projects may be submitted. Individual project investigators
may propose either a research project or a pilot research project, but
not both.
Each research project or pilot research project should follow the
instructions provided in PHS 398 (Revised 9/2004, Interim Revision 4/
2006) for preparing research grant applications. The professional
development goals must clearly describe specific objectives and
milestones which should include, but are not limited to, improving
competitiveness in acquiring grant support. The applicant should
described how successful completion of the proposed research project
will improve the research skills and will help develop the students and
faculty/researchers, thus contributing to the overall goals and
specific measurable objectives of the proposed NARCH.
Each research project or pilot research project must follow the IHS
policy concerning Tribal approval, that all research involving AI/AN
Tribes be approved by the Tribal governments with jurisdiction. That
is, each grantee must include a resolution of approval from the Tribal
government(s), or (if applicable) a letter of support signed by the
director of the eligible AI/AN
[[Page 4239]]
organization, or both (if applicable) for projects that involve people
or community(ies) of an AI/AN Tribe, or an eligible Tribal
organization.
Research projects (including pilot research projects) proposed
under this initiative must be in research areas normally funded by any
of the NIH or other research agencies in the HHS. Research projects
addressing health disparities and the health priorities of the AI/AN
partner are especially encouraged.
A listing of grants recently funded by NIH may be found at Computer
Retrieval of Information on Scientific Projects (CRISP), a searchable
database of Federally funded biomedical research projects conducted at
universities, hospitals, and other research institutions. It may be
accessed at https://ott.od.nih.gov/crisp.html.
The following agencies, institutes, offices and centers have stated
particular interests in supporting research under the NARCH Program as
follows:
National Institute of Dental and Craniofacial Research (NIDCR)
Oral Health Research
NIDCR is committed to reducing the disproportionate burden of oral
diseases experienced by AI/ANs. The focus of NIDCR's health disparities
research is on improving oral health status and quality of life by
understanding and addressing oral diseases that are prevalent in AI/AN
communities, specifically caries (including early childhood caries),
oral and pharyngeal cancer, and periodontal disease. Interdisciplinary
research teams and the full participation of communities are viewed by
NIDCR as essential components of any health disparities research.
Data that document oral disease prevalence are readily available
for some populations, but not for others. Homogeneity in subgroups of
populations cannot be assumed. For instance, there are national data
for Mexican Americans, but not for the numerous other Hispanic
subgroups. Similarly, data regarding the oral health status of various
AI/AN Tribes are unavailable. Moreover, available data provide little
insight into the etiology or determinants of oral disease and oral
health. The paucity of quality data and conceptual models concerning
the broad array of potential determinants and risk-factors inhibits
progress toward preventing disease, and improving oral health status
and quality of life. The NIDCR invites applications that, in
preparation for intervention research, explore the complex array of
social, behavioral, psychological, contextual, environmental and
biological factors and their interactions that may contribute to oral
health disparities within AI/AN communities. Including oral health
status measures within broader epidemiologic studies is encouraged.
However, applications that are limited to the assessment of disease
prevalence and that explore a very limited range of potential
determinants will be considered non-responsive.
The NIDCR has particular interest in intervention research that
will provide clinically meaningful outcomes and essential information
needed to inform clinical practice, public health policy, health care
provision, community and/or individual action. Intervention studies
that are grounded in theory are needed. Both basic and applied
intervention research applications are invited. Studies may need to
intervene at multiple levels within communities. The NIDCR encourages
the use of the strongest research design possible and recognizes that
not all intervention research is amenable to randomized clinical
trials. Examples of health disparities intervention research of
interest to the NIDCR includes but are not limited to:
Effectiveness studies that tailor/target preventive
approaches to communities/individuals;
Research that intervenes in novel ways on macro- or
intermediate level determinants of oral health status;
Health services research that explores alternative
approaches to delivering preventive oral health care;
Studies that intervene on common risk factors or that take
a systems approach;
Studies that explore multifaceted strategies to intervene
at several levels within society;
Dissemination and implementation research at multiple
organizational levels; and
Research that uses appropriate technology for translation,
implementation, adoption, adherence and acceptance of oral disease
prevention programs in defined populations, clinics, and communities.
Intervention research should be reasonably applicable to a specific
AI/AN population. To facilitate adequate enrollment and
generalizability, intervention studies may need to be conducted at
multiple sites. While small clinical trials are not permitted, studies
may be conducted at a single site if enrollment is adequate and if
sufficient numbers of participants are available to allow extrapolation
of clinically meaningful results to the specific AI/AN population of
interest.
Pilot research projects that are designed to lead to larger
research projects funded as part of a center or as free-standing NIH
grants may be proposed.
For additional information about oral health research contact:
Ruth Nowjack-Raymer, M.P.H., Ph.D., Director, Health Disparities
Research Program, National Institute of Dental and Craniofacial
Research, 45 Center Drive, Room 4AS-43F, Bethesda, MD 20892-6401,
Phone: (301) 594-5394, Fax: (301) 480-8322, E-mail:
nowjackr@mail.nih.gov.
National Institute on Drug Abuse (NIDA)
Neuroscience and Drug Abuse Research
AI/ANs demonstrate higher rates of drug abuse, particularly
methamphetamine, tobacco and alcohol abuse, relative to other racial
subgroups. According to 2002-2006 National Survey on Drug Use and
Health (NSDUH) data, AI/AN past year methamphetamine use was 1.4%
compared to 0.1% for African Americans, 0.6% for Hispanics or Latinos
and 0.7% for Whites. Prevalence of use is high in both men and women.
Drug abuse patterns among AI/AN are complex and can vary by factors
such as Tribe and geographic location. While some datasets are
available that can provide general epidemiological data regarding use
and abuse rates in this group, data are needed that better clarify
where use rates are highest, among which Tribes, age and gender groups
and the factors that predict drug abuse in these locales and groups.
These data will assist in developing more targeted interventions and in
identifying mechanisms related to drug abuse which can then serve as
focal points for intervention.
In addition to scarce data on patterns of use, limited data are
available assessing drug abuse prevention and treatment interventions
for AI/AN. The matrix model has been proposed in particular to address
methamphetamine abuse, but few data are available to assess the
efficacy of this approach with this population. Several preventive
interventions have been designed particularly for this population and
results from them indicate their value, but more research is needed to
clarify why these sometimes don't work in expected ways and whether the
interventions that are being used but have not been evaluated are
working to reduce drug use.
[[Page 4240]]
The NIDA is committed to reducing health disparities in drug abuse
and related health and social consequences among AI/AN. Further, the
Institute supports methodologies required by the NARCH, expecting that
studies be developed and implemented using community participatory
approaches.
Research topics of interest include but are not limited to:
Studies that explore a range of behavioral, cultural,
environmental and individual factors that contribute to drug abuse;
Studies that explore the consequences of drug abuse among
AI/AN;
Studies that consider the full context of drug abuse,
including poverty, family factors, school factors, intergenerational
trauma, etc.;
Studies that explore the role of traditional practices and
spirituality in protecting against drug abuse;
Studies that explore other factors that protect against
use in those groups for whom use rates are lower;
Studies that explore the efficacy and/or effectiveness of
culturally relevant preventive interventions;
Studies that explore the efficacy and/or effectiveness of
culturally relevant treatment interventions;
Studies that assess factors related to service
utilization, including use rates and access to services, either in
reservation or urban settings; and
Studies that explore the organization, management and
delivery of interventions.
For additional information about neuroscience or drug abuse
research contact: Kathy Etz, PhD, National Institute on Drug Abuse,
6001 Executive Blvd., Room 5153 MSC 9589, Bethesda, MD 20852, Phone:
(301) 402-1749, Fax: (301) 480-2543.
National Cancer Institute (NCI)
Tobacco Control Research
AI/ANs have been documented to have the highest smoking rate of any
major racial/ethnic group in the U.S. According to the 2005 National
Health Interview Survey of adults 18 and over, 32% of AI/AN are current
smokers, compared with 21.9% of non-Hispanic whites, 21.5% of non-
Hispanic Blacks, 13.3% of Asians and 16.2% of Hispanics. Prevalence of
smoking is high among both men (37.5%) and women (26.8%).\1\ A similar
pattern can be seen among youth, where AI/AN youth have substantially
higher smoking prevalence (23.1%) than non-Hispanic whites (14.9%),
Hispanics (9.3%), non-Hispanics blacks (6.5%), and Asians (4.3%),
according to data from the National Survey on Drug Use and Health.
These data also show that non-smoking AI/AN youth demonstrated higher
susceptibility to experimenting with smoking than most other racial/
ethnic groups.\2\
At the same time, however, tobacco use patterns among the AI/AN
population are complex and can vary substantially among subgroups of
this population. Smoking rates among AI/ANs vary widely by region,
being highest in the northwestern United States, in Canada, and in
Alaska. Additionally, use of smokeless tobacco is higher among AI/AN
adults compared with other racial/ethnic groups. Some studies have
found particularly high rates of smokeless tobacco use (greater than
50%) among AN populations, including pregnant women, due to the use of
Iqmik, a traditional form of smokeless tobacco.\3\
Understanding tobacco use among Native American populations is also
complicated by the fact that tobacco has had a substantial role in
Native American culture and tradition. Historically, tobacco has been
used in medicinal and healing rituals and in ceremonial and religious
practices. It is important to distinguish the traditional, ceremonial
uses of tobacco, which are limited to specific occasions, from
addictive use of tobacco products. However, the relationship between
these different contexts of tobacco use and their impact on behavior
has not received sufficient scientific study.
Moreover, limited data are available on the effectiveness of
tobacco use cessation interventions targeted to AI/ANs. Preliminary
focus group studies suggest that Native American smokers are more
likely to have negative attitudes towards pharmacotherapies, such as
concerns about side effects and lack of trust in conventional
medicine.\4\ Thus, there is a need to develop culturally-appropriate
interventions targeted to this population.
The NCI Tobacco Control Research Branch is committed to supporting
transdisciplinary research aimed at reducing disparities in tobacco use
and related health outcomes. The NARCH provides a unique mechanism to
support collaborative research involving researchers from multiple
disciplines to address a complex scientific and public health
challenge.
Sample research areas of interest include but are not limited to
the following:
Studies to understand the role of a range of behavioral,
cultural and environmental factors that lead to initiation of tobacco
use among AI/AN populations.
Development and evaluation of culturally appropriate
interventions for tobacco use prevention and cessation targeted to AI/
AN populations;
Studies of how tobacco related attitudes and behaviors in
youth and adults are influenced by ceremonial tobacco use and other
cultural factors;
Studies of tobacco use behavior in relation to different
products, including dual use of cigarettes and smokeless tobacco;
Research on the characteristics, use and health effects of
traditional tobacco products, such as Iqmik;
Research to understand disparities in tobacco use within
AI/AN populations given substantial variations by region and other
factors; and
Studies to identify and address barriers to treatment
among AI/ANs.
References
1. Tobacco Use Among Adults--United States, 2005. MMWR. October 27,
2006; 55: 1145-1148.
2. Racial/Ethnic Differences Among Youths in Cigarette Smoking and
Susceptibility to Start Smoking--United States, 2002-2004. MMWR.
December 1, 2006; 55; 1275 1277.
3. Renner CC, Pattern CA, Day GE, Enoch CC, Schroeder DR, Offord
KP, Hurt RD, Gasheen A, Gill L. Tobacco use during pregnancy among
Alaska Natives in western Alaska. Alaska Med. 2005;47:12-6.
4. Burgess D, Fu SS, Joseph AM, Hatsukami DK, Solomon J, van Ryn M.
Beliefs and experiences regarding smoking cessation among American
Indians. Nicotine Tob Res. 2007; 9 Suppl 1: S19-28.
For additional information about NCI tobacco research contact: Mark
Parascandola, PhD, Epidemiologist, Tobacco Control Research Branch,
National Cancer Institute, 6130 Executive Blvd. MSC 7337, Executive
Plaza North, Room 4039, Bethesda, MD 20892, Phone: 301-451-4587, Fax:
301-496-8675, paramark@mail.nih.gov.
National Heart, Lung, and Blood Institute (NHLBI)
Cardiovascular and Respiratory Research
The NHLBI has a strong history of supporting research to document
and intervene on health disparities among AI/ANs, including the Strong
Heart Study, Pathways, Genetics of Coronary Artery Disease in Alaska
Natives (GOCADAN), the Stop Atherosclerosis in Native Diabetics Study
(SANDS), and Community-Responsive Interventions to Reduce
Cardiovascular Risks in AI/ANs.
The Strong Heart Study showed that many AI/AN communities bear a
heavy
[[Page 4241]]
burden of cardiovascular disease (CVD) and cardiovascular risk factors
(e.g., obesity, diabetes) that could be reduced through effective
interventions on modifiable risk factors. The high burden of disease
will worsen unless behaviors and lifestyles affecting CVD risk can be
changed. Prevalence of obesity in AI/AN communities is about 50% higher
than in the U.S. general population in which obesity is often described
as being of epidemic proportions. In some AI/AN communities, cigarette
smoking, sedentary lifestyle, and stress augment the adverse effects of
obesity. AI/AN are particularly vulnerable to Type II diabetes, a
problem exacerbated by high rates of obesity. Diabetes prevalence is 3-
20 fold higher among AI/AN than in the general U.S. population. It is
an important cause of coronary heart disease, cardiomyopathy, end-stage
renal disease, non-traumatic amputation, and vision impairment. Lipid
abnormalities also are common in Type II diabetics,, particularly high
triglycerides and low HDL-cholesterol levels. Dyslipidemia and blood
pressure can be improved by appropriate changes in diet and by
increased exercise. CVD risk is also substantially improved by smoking
cessation. In addition, attention to high stress levels, untreated
sleep disordered breathing, short sleep duration, and depression may be
warranted because of evidence that they may influence the health
behaviors of interest. For example, poorer diet, higher smoking rates,
and physical inactivity are more prominent in those with high stress,
sleep disorders, or depression. These psychosocial factors also are
associated with CVD progression in observational epidemiologic studies,
and there is evidence from smaller clinical studies they may affect
mechanisms leading to CVD. NHLBI is interested in supporting research
in AI/AN communities that promote the adoption of healthy lifestyles
and/or improve behaviors related to cardiovascular (CV) risk, such as
weight reduction, regular physical activity, and smoking cessation.
These behaviors and lifestyles are known to affect biological
cardiovascular risk factors, such as hypertension, dyslipidemia,
obesity, glucose intolerance, and diabetes. In addition, control of
these risk factors by guideline-based use of antihypertensive, lipid
lowering, and hypoglycemic drugs can reduce their adverse consequences.
However, these pharmacological interventions are often suboptimally
utilized in AI/AN communities. The NHLBI is interested in reducing
cardiovascular disease mortality and morbidity in AI/AN, whether by
lifestyle changes, drug interventions, or combinations thereof.
Lifestyles characterized by sleeping less than 5-6 hours per night
are associated with increased risk of CVD, obesity, and diabetes.
Insufficient sleep as a behavioral stressor is associated with risk of
new onset substance abuse and relapse, and depression risk and relapse.
Intervention studies to assess the efficacy of improving sleep as part
of a healthy lifestyle or assessing how improving sleep disorders could
improve CVD outcomes would be of interest to NHLBI.
AI/AN also have been documented to exhibit high rates of chronic
respiratory disease. AI/AN adults have the highest asthma rate among
single-race groups. Recent evidence suggests that 11.6 percent of AI/AN
suffer from asthma. This is significantly higher than the national
average of 7.5 percent, and much higher than every other single racial
or ethnic group. Chronic obstructive pulmonary disease (COPD), which
includes emphysema and chronic bronchitis, is the eighth leading cause
of death from chronic disease for AI/AN men and the sixth leading cause
of death for women. AI/AN have the second highest rates of cystic
fibrosis following whites. One in 10,500 AI/AN has cystic fibrosis
compared with one in 3,500 whites. Pueblo Indians and Zuni Indians have
higher incidence than among other AI/AN Tribes. Sleep disordered
breathing appears to be 30-60% more common among American Indians than
other racial and ethnic groups. NHLBI is interested in supporting
research in AI/AN communities that includes studies of approaches to
improve clinical delivery of efficacious treatments of chronic lung
disease and their risk factors, improved methods of chronic lung
disease self-management, studies to promote or maintain respiratory
health or improved methods of rehabilitation for diseases of the lungs
and airways, such as asthma, emphysema, cystic fibrosis; sleep
disordered breathing, occupational lung diseases, pulmonary vascular
disease or pulmonary complications of Acquired Immune Deficiency
Syndrome (AIDS).
In addition to these areas of research, the NHLBI recognizes a
unique and compelling need to promote diversity in the biomedical,
behavioral, clinical, and social sciences research workforce. The NHLBI
expects efforts to diversify the workforce to lead to:
The recruitment of the most talented researchers from all
groups;
An improvement in the quality of the educational and
training environment;
A more balanced perspective in the determination of
research priorities;
A improved capacity to recruit subjects from diverse
backgrounds into clinical research protocols; and
An improved capacity to address and eliminate health
disparities.
For more information, please contact: Jared B. Jobe, Ph.D.
(Cherokee), Program Director, Clinical Applications and Prevention
Branch, Division of Prevention and Population Sciences, National Heart,
Lung, and Blood Institute, 6701 Rockledge Drive, Suite 10018, MSC 7936,
Bethesda, Maryland 20892-7936 (20817 express), Phone: (301) 435-0407,
Fax: (301) 480-5158, JobeJ@mail.nih.gov (e-mail).
National Institute of Arthritis and Musculoskeletal and Skin Diseases
(NIAMS)
Research in Osteoporosis and Other Bone Diseases, Osteoarthritis,
Rheumatoid Arthritis and Skin Disease Within the NIAMS Mission
The NIAMS supports efforts to conduct research into the causes,
treatment, and prevention of arthritis and musculoskeletal and skin
diseases; the training of basic and clinical scientists to carry out
this research; and the dissemination of research progress to improve
the public health. Goals specific to the AI/AN communities involve
research addressing the training of underrepresented minority AI/AN
researchers and ensuring inclusion of Native communities in clinical
research studies. NIAMS actively monitors the inclusion of minority
populations in clinical research and will highlight any grants that
specifically target AI/AN populations. The mission of the NIAMS is to
support research into the causes, treatment, and prevention of
arthritis and musculoskeletal and skin diseases, the training of basic
and clinical scientists to carry out this research, and the
dissemination of information on research progress in these diseases.
Studies in these mission areas as they relate to the AI/AN population
may be proposed.
For additional information about research in these areas contact:
Madeline Turkeltaub, CRNP, Ph.D., Deputy Director, Extramural Program,
National Institute of Arthritis and Musculoskeletal and Skin Diseases,
6701 Democracy Blvd., Suite 800, Bethesda, MD 20912, Phone: (301) 594-
2463, Fax: (301) 480-4543, E-mail: mturkeltaub@mail.nih.gov.
[[Page 4242]]
National Center for Complementary and Alternative Medicine (NCCAM)
Research on Traditional Healing Practices
Many AI/AN communities use traditional healing practices to prevent
and/or treat diseases and to maintain health. NCCAM is interested in
supporting research on traditional healing practices with these goals
in mind. NCCAM is also interested in research on the safe and effective
integration of conventional care with traditional healing practices for
AI/AN communities. The methodological feasibility for integration has
yet to be addressed for many traditional healing practices.
Consequently, NCCAM is interested in supporting developmental studies
to identify and address difficult methodological and design issues
particular to traditional healing practices, as well as to allow for
the development of contextually and culturally sensitive research
mirroring the values of AI/AN communities.
Examples of study areas of interest include, but are not limited
to:
Qualitative research to characterize and document healing
practices and diagnostic approaches of indigenous peoples, and study
the feasibility of research on those practices and approaches in future
clinical studies;
Observational studies to explore patient and care provider
preferences, beliefs, attitudes, and patient-provider interactions;
Case-control, observational, and other studies to
understand traditional healing strategies from multiples perspectives,
including: (a) Optimal dosing, duration, and frequency of treatment;
(b) type of treatment; (c) examinations of different healing practices
to treat a particular disease/condition; (d) comparisons of complex
versus simple interventions; (e) evaluation of adherence among patient
populations to interventions with varying levels of complexity; and (f)
examination of potentially important individual differences that
mediate or moderate treatment outcome;
Studies to determine if traditional healing practices can
be translated into a broader clinical setting, in terms of:
Reliability, responsiveness, and utility; assessment procedures,
instruments, and tools in psychosocial, functional, and physiological
domains;
Studies to construct and validate culturally sensitive
data collection instruments; to design and pilot outcome measures
consistent with the tenets of traditional, indigenous systems of
medicine and comparisons of these outcome measures to those commonly
used by conventional biomedicine; and
Health services research of established AI/AN traditional
healing practices to explore the factors that influence access to and
use of such therapies; the nature, cost effectiveness, and quality of
such care; and ultimately the effects on health and well-being.
For additional information on NCCAM-supported research topics,
contact: Peter J. Kozel, Ph.D., National Center of Complementary and
Alternative Medicine, 6707 Democracy Boulevard, Suite 401, MSC 5475,
Bethesda, MD 20892-5475, Phone: (301) 496-8004, Fax: (301) 480-3621,
kozelp@mail.nih.gov.
Office of Research on Women's Health (ORWH)
Women's Health Research
The ORWH at the NIH supports research related to women's health and
the study of sex and gender differences. Detailed information about the
NIH Research Priorities for Women's Health, can be found at https://
orwh.od.nih.gov/research.html.
For additional information on women's health research, contact:
Lisa Begg, DrPH., RN, Director of Research Programs, NIH Office of
Research on Women's Health, 6707 Democracy Blvd., Suite 400, Bethesda,
MD 20892-5484, Phone: (301) 496-7853, Fax: (301) 402-1798,
beggl@od.nih.gov.
National Institute of Mental Health (NIMH)
Research projects aimed at understanding the burden, treatment or
prevention of mental disorders and Human Immunodeficiency Virus (HIV)/
AIDS in AI/AN populations.
Indigenous people in the United States are disproportionately
affected by mental illness and HIV infection, as are the larger racial
and ethnic populations such as African Americans and Latinos. AI/ANs
are highly underrepresented in the physician workforce and as
researchers in health research in general, numbering fewer than one
hundred.
Other factors that contribute to disparities that affect these
communities include geographic isolation, poor access to health
services, underutilization of health services, insufficient screening
and partner management services, unique social norms, stigma and gender
dynamics. Research is needed to identify and address the impact as well
as the specific and unique aspects of mental disorders and HIV
infection upon Native American communities. A critical component of
response to mental health and HIV infection in Native American
communities will be to identify, train, mentor, and develop Native
American investigators. Towards these ends, a promising model is
community-based participatory research together with community capacity
building.
Some NIMH research areas that can contribute to scientific
knowledge about mental health and HIV interventions in Native Americans
includes:
Research methods/community assessment;
Studies of the impact of traumatic stressors, studies of
patient, provider and contextual factors;
Intervention research to evaluate the effectiveness of
pharmacologic, psychosocial (psychotherapeutic and behavioral),
somatic, rehabilitative and combination interventions on mental and
behavior disorders-including acute and longer-term therapeutic effects
on functioning for children, adolescents, and adults;
Studies of services organization, delivery (process and
receipt of care), and related health economics at the individual,
clinical, program, community and systems levels in specialty mental
health, general health, and other delivery settings (such as the
workplace);
Interventions to improve the quality and outcomes of care
(including diagnostic, treatment, preventive, and rehabilitation
services);
Studies to enhance the research infrastructure for
conducting services research; studies of clinical epidemiology of
mental disorders across all clinical and service settings;
Scientifically rigorous investigation of culturally
appropriate prevention and control strategies;
Adaptation, evaluation, safety and costs of proven
interventions;
Dissemination and implementation strategies; and,
The role of community stakeholders in the research
process, especially readiness for change.
For additional information on NIMH NonAIDS Applications contact:
Carmen P. Moten, Ph.D., Chief, Primary Care, Socio Cultural and
Disparities Research Programs, Division of Services and Intervention
Research, National Institute of Mental Health, 6001 Executive
Boulevard, Room 7131, MSC 9631, Bethesda, MD 20892-9631, Telephone:
(301) 443-3725, FAX: (301) 443-4045, E-mail: cmoten@mail.nih.gov.
For additional information on NIMH HIV/AIDS-related applications
contact: David M. Stoff, Ph.D., Chief: HIV/AIDS Neuropsychiatry
Program, AIDS
[[Page 4243]]
Research Training and HIV/AIDS, Disparities Program, Division of AIDS
and Health and Behavior Research, National Institute of Mental Health,
6001 Executive Boulevard, Room 6210, MSC 9619, Bethesda, MD 20892-9619,
Telephone: (301) 443-4625, FAX: (301) 443-9719, E-mail:
dstoff@mai1.nih.gov.
National Library of Medicine (NLM)
Biomedical Informatics and Knowledge Management
NLM supports research into how computers and networks can best be
used to capture, represent, store, retrieve, manipulate, manage, and
disseminate information for use in health care and public health,
health education, and biomedical research. These informatics research
projects must be user-centered, aimed at meeting needs of health care
providers, consumers, students, researchers, and policy makers. To be
user centered, information systems must be usable and useful, and
information must be understandable to the audience for whom it is
intended, accurate, and timely. The knowledge people need to
participate in their own health care and the care of others is complex
and comes from many sources. Important research questions remain to be
answered about the most effective ways to bring these different sources
together when and where they are needed. Informatics is by nature an
interdisciplinary field, and the training of researchers for
informatics careers involves coursework in the concepts and practices
of information and computer science as well as in domains of health and
biomedicine. NLM offers training programs at 18 academic organizations,
for pre and post-doctoral trainees who wish to pursue a career in
informatics. Many of these organizations offer special short-term
traineeships of three months that provide a trainee with an
introduction to informatics research.
For additional information about NLM programs contact: Valerie
Florance, Ph.D., Deputy Director, NLM Extramural Programs, Rockledge 1,
Suite 301, 6705 Rockledge Drive, Bethesda, MD 20892, Phone: (301) 594-
4882, Fax: (301) 402-2952, Web site: https://www.nlm.nih.gov/ep NLM/NIH/
DHHS.
National Institute of Biomedical Imaging and Bioengineering (NIBIB )
Research in Technology for Health
The National Institute of Biomedical Imaging and Bioengineering
(NIBIB) is committed to reducing health disparities through the
development of new and affordable biomedical technologies. To this end,
the NIBIB is interested in supporting the translation of biomedical
technologies that target the health needs of AI/AN communities.
Specifically, the NIBIB is interested in supporting the development of
technologies that have broad therapeutic and interventional
applications as well as technologies that complement technology
development in all program areas of the NIBIB, https://
www.nibib.nih.gov/Research/ProgramAreas.
For additional information about NIBIB programs contact: John W.
Haller, PhD., National Institute of Biomedical Imaging and
Bioengineering, NIH/DHHS, 6707 Democracy Blvd. Suite 200, Bethesda, MD
20892-5649, E-mail: hallerj@mail.nih.gov, Phone: (301) 451-4780, Fax:
(301) 480-1614.
National Eye Institute (NEI)
Vision Research
The NEI supports research and health information dissemination with
the goal of protecting and prolonging the vision of the American
people. Examples of such activity that may be of interest include, but
are not limited to:
Epidemiological studies to determine the prevalence and
possible risk factors of eye diseases and disorders among AI/AN
populations;
Basic research studies into the causes and mechanisms of
eye diseases and visual impairments in AI/AN, research into disparities
in access to ophthalmic/optometric health services; and,
Development and evaluation of culturally appropriate
health education and intervention.
For additional information on vision research topics contact:
Jerome R. Wujek, Ph.D., National Eye Institute, 2020 Vision Place,
Bethesda, MD 20892-3655, Phone: (301) 451-2020, Fax: (301) 402-0528, E-
mail: wujekjer@nei.nih.gov.
The omission above of any NIH institute, center, office, or
research area should not be taken as a lack of availability of support
for proiects in those areas. NARCH is an NIH-wide partnership, led at
NIH by the National Institute of General Medical Sciences (NIGMS).
General research priorities for all of the individual NIH Institutes,
Centers, Divisions and Offices can be found on their respective Web
sites at: https://www.nih.gov/icd/. However, applicants and
potential academic partners are reminded that that the NARCH program is
focused on the research needs of the Tribes and not those of the
Federal or academic partners.
Public Policy Requirements: All Federal-wide public policies apply
to IHS grants with exception of Lobbying and Discrimination public
policy.
3. Submission Dates and Times:
A. Letter of Intent Deadline: March 15, 2008.
Prospective applicants are asked to submit a letter of intent that
includes the